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Teaching of cardiovascular prevention and rehabilitation in European medical
schools 2009:results of a first institutional survey
P Marques-Vidal1, H Saner2
1University Hospital Center Vaudois, Lausanne, Switzerland, 2Bern University Hospital,
Cardiovascular Prevention and Rehabilitation, Bern, Switzerland
Topic: Health services research
Background: Little is known regarding the teaching of cardiovascular prevention and rehabilita-
tion (CVP&R) in Europe.
Design: cross-sectional institutional survey.
Methods: A questionnaire was sent to 376 European medical schools, 44 National Cardiology
Societies, 31 Heart Foundations and 32 National Medical Associations.
Results: One hundred and twenty medical schools (32% response rate) answered. Forty-three
postgraduate courses on CVP&R were provided in 32 (27%) schools. The median number of
students was 25 (range: 4 - 140) and the median number of teaching hours was 72 (range: 3 - 518).
The topics most frequently taught were cardiovascular risk factors (86%), physical activity
(81%), global risk estimation and smoking cessation (both 74%). For the 26 countries for which
data was available, 14 (54%) had postgraduate teaching on CVP&R but only three (12%)
provided continuous medical education on the topic. Teaching was aimed essentially at
cardiologists; in two countries, internists, neurologists and other health professionals (nurses,
paramedics) could also attend CVP&R postgraduate courses.
Conclusion: teaching of CVP&R is low in European medical schools, and the courses provided
differ considerably between countries and schools. There is a great need to provide a minimal
educational framework to ensure adequate training in CVP&R throughout Europe.
P326
Cardiovascular prevention in Russia: primary care physicians knowledge seems to be
an obstacle
N Pogosova, RG Oganov, IY Koltunov, VA Vigodin, OY Sokolova
National Center for Preventive Medicine, Moscow, Russian Federation
Topic: Health services research
Aim:To assess primary care physicians beliefs and knowledge concerning secondary prevention
in patients with arterial hypertension (AH) and coronary heart disease (CHD) in the Russian
Federation.
Materials and methods: A multicenter study RELIF (REgularnoe Lechenie I proFilaktika ) has
been performed in 20 big cities of Russia: in each city were randomly selected 5 polyclinics, in
each policlinic 5 general practitioners (GPs). All GPs (N¼512) filled out questionnaire
containing questions on their demographic data, employment, postgraduate medical education,
access to professional information, awareness of National and European guidelines on AH and
CHD treatment, knowledge on cardiovascular risk factors (RF) and their goals.
Results: The average age of participating GPs was 44.2þ10.4 years, average work experience
16.7þ10.6 years, 89.64% were female. 89% of GPs have completed postgraduate training
programs as required by National authorities. 85.4% of GP s reported to be trained in prevention
counseling. In previous 5 years they attended 7.2þ6.9 scientific congresses and received
9.4þ10.3 medical journals, newspapers, print materials on treatment and prevention of cardi-
ovascular diseases. 85% of GPs reported that they have read the National guidelines and 67.8%
of GPs guidelines of the European Society of Cardiology on AH and CHD treatment. While
answering opened questions on the RF of CHD, 74.68% of physicians named smoking, 70.17%
obesity, 53.0% dyslipidemia, 44.42% low physical activity, 40.13% family history of premature
CHD, 38.84% stress, 30.26% diabetes, 25.54% - age, 19.31% AH, and only 12.45% - male sex.
70.9% of GPs exactly mentioned the BP cut points for AH I,II and III degrees. 27.8% were aware
of target levels for total cholesterol, 11.5% for LDL cholesterol, 51.9% for HDL cholesterol in
CHD patients. 72.8% of GPs knew normal ranges of body mass index, but only 40% were
familiar with limits of waist circumference. 60.9% of GPs were mistaken while estimating the
recommended salt intake for AH patients, at the same time 66.9% knew the proper duration of
daily aerobic activity.
Conclusion: Present study has shown a low level of GPs knowledge on cardiovascular RF and
their secondary prevention goals which can indicate a poor efficacy of current postgraduate
training programs and guideline implementation strategies.
P327
HAPIEE study: Dietary patterns and their association with socio-demographic factors
in Lithuanian urban population
DI Luksiene, M Baceviciene, A Tamosiunas, R Radisauskas, R Reklaitiene, E Dau-
geliene
Institute of Cardiology of Kaunas University of Medicine, Kaunas, Lithuania
Topic: Nutrition
Traditionally nutritional research has focused primarily on single nutrients or food, interest is
growing in dietary patterns that consider the complexity of the overall diet.
The aim of the study was to identify the main dietary patterns in Lithuanian urban population
and to determine their association with socio-demographic factors.
Material and methods: Data from the survey performed in the framework of the international
HAPIEE (Health, Alcohol, and Psychosocial factors in Eastern Europe) study are presented. A
random sample of Kaunas men and women aged 45-72 years, stratified by gender and age was
randomly selected from Lithuanian population register. 7087 individuals were screened.
Response rate was 60.5%. Factor analysis was performed in order to reduce the number of
food items. A five-factor solution which accounted 47.8% of the total variance was indicated. The
association between dietary patterns and socio-demographic factors was analyzed by logistic
regression.
Results: The first ‘‘fresh vegetables, fruit’’ factor and the second ‘‘sweets’’ factor were inversely
associated with age: older people consumed less frequent than average of particular food groups
(p<0.001). Conversely, third factor ‘‘porridge, cereals’’ was directly associated with age: older
people favored this diet (p<0.001). The fourth factor ‘‘potatoes, meat, boiled vegetables, eggs’’
was directly associated with age only in women group (p<0.01). The fifth factor ‘‘chicken, fish’’
was not associated with age. Men and women with university education were more likely to
follow the ‘‘fresh vegetables, fruit’’ and ‘‘porridge, cereals’’ patterns and less likely ‘‘potatoes,
meat, boiled vegetables, eggs’’ pattern than people with secondary education: in men - odds
ratio (OR)-1.51; OR-1.33 and OR-0.74 respectively (p<0.01); in women - OR-1.72; OR-1.42 and
OR-0.69 respectively (p<0.01). Married men and women were more likely to follow ‘‘fresh
vegetables, fruit’’ and ‘‘potatoes, meat, boiled vegetables, eggs’’ patterns than single people
(p<0.001); also married women favored the ‘‘chicken, fish’’ diet than single women (p<0.05).
Men and women who self-rated health as poor were less likely to follow the ‘‘fresh vegetables,
fruit’’ and ‘‘sweets’’ patterns than people with good health: in men - OR- 0.62 and OR-0.73
respectively (p<0.05); in women - OR-0.55 and OR-0.79 respectively (p<0.05).
Conclusion: This study identified five main dietary patterns in Lithuanian urban population.
Dietary patterns of people with university education, married and good self-rated health are
healthier than among people with lower education, single and poorer health.
P328
Adherence to the Mediterranean dietary pattern is inversely associated with small
dense low-density lipoprotein (sdLDL) phenotype B: the ATTICA Study
CMKastorini1, DB Panagiotakos1, C Chrysohoou2, C Pitsavos2, J Skoumas2, S Vellas2,
M Kambaxis2, C Stefanadis2
1Harokopio University, Athens, Greece, 2Hippokration Hospital, 1st Department of Cardiology of
the University of Athens, Athens, Greece
Topic: Nutrition
Objective: Lipoprotein phenotype B is characterized by a predominance of small dense LDL
particles and is associated with increased risk for developing coronary heart disease. The aim of
the present work is to examine the relationship between adherence to the Mediterranean dietary
pattern and the level of small dense LDL-cholesterol.
Methods: The ATTICA study is a population-based cohort that has randomly enrolled 1528
men and 1514 women (aged > 18 years old), stratified by age gender, from the greater area of
Athens, during 2001-2002. Adherence to Mediterranean diet was assessed through the Med-
DietScore (theoretical range 0-55). The LDL-cholesterol/LDL-apo-B ratio was calculated using
the formula (0.94chol0.94HDL0.19TG)/(apo B0.09cholþ0.09HDL0.08TG). Lower levels of
this ratio indicate the presence of small dense LDL.
Results: After controlling for several potential confounding factors, participants in the lowest
tertile and in the second tertile of the MedDietScore (i.e., <, lower adherence to the
Mediterranean diet), had lower LDL-cholesterol/LDL-apo B ratio, compared with those in
the highest tertile (B¼-0.063, p¼0.012 and B¼0.049, p¼0.009, respectively). In addition
multiple logistic regression analysis, showed that participants following very closely the
Mediterranean dietary pattern have 36% (95%CI: 0.42-0.96) lower likelihood of having levels
of the LDL-cholesterol/LDL-apo B ratio below the median, i.e., 1.35, compared with those who
follow a more western diet.
Conclusions: Adherence to the Mediterranean dietary pattern has a protective effect regarding
the presence of the more atherogenic small dense LDL particles that are considered a major risk
factor for cardiovascular disease.
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Effects of nuts on coronary heart disease risk factors in type 2 diabetes
C Kendall, A Esfahani, S Mitchell, T Parker, M Banach, JA DavidJenkins
University of Toronto, Toronto, Canada
Topic: Nutrition
Background: Diabetes is associated with a significant increase risk in the development of
cardiovascular disease (CVD). While recent studies indicate that nut consumption can improve
CVD risk factors in hyperlipidemic subjects, few studies have investigated their effect in type 2
diabetes.
Objective: To determine if consumption of nuts improves CVD risk factors and glycemic
control in type 2 diabetes.
Methods: 117 subjects with type 2 diabetes were randomized to a 3-month parallel design study.
Subjects were randomized to one of three treatments: 1) Test (Full Dose Nut Diet): 75g/d for
2,000kcal/d; 2) Test (Half Dose Nut Diet): half-dose of nuts and half-dose of control muffin; and
3) Control: whole wheat muffins matched with energy content of nut supplements. Fasting
blood samples were collected at baseline and weeks 2, 4, 8, 10 and 12 for markers of glycemic
control and CVD risk factors.
Results: Compared to the control, the full dose nut supplement significantly lowered HbA1c
(P¼0.039), total-C (P¼0.002), LDL-C (P¼0.007), total-C:HDL-C (P¼0.015), and LDL-
C:HDL-C (P¼0.028). The half-dose of nuts did not result in any significant improvements
in blood lipids or glycemic control.
Conclusions:The addition of nuts to the diet improves reduces blood lipid CVD risk factors and
glycemic control in type 2 diabetes.
P330
Long-term plant and animal protein consumption are associated with likelihood of
developing left ventricular systolic dysfunction, in acute coronary syndrome patients
CM Kastorini1, C Chrysohoou2, DB Panagiotakos1, P Aggelopoulos2, C Pitsavos2, C
Stefanadis2
1Harokopio University, Athens, Greece, 2Hippokration Hospital, 1st Department of Cardiology of
the University of Athens, Athens, Greece
Topic: Nutrition
Background and Aims: The aim of the present work was to evaluate the association between
plant and animal protein consumption and the development of left ventricular systolic
dysfunction (LVSD) in patients who have had an acute coronary syndrome (ACS).
Methods: During 2006-2009, 1000 consecutive ACS patients were included in the study; 459
patients who developed LVSD, 367 males (6414 years) and 92 females (7112 years) and 541
patients with preserved systolic function, 421 males (6212 years) and 120 females (6712
years). Detailed information regarding their medical records, anthropometric data, physical
activity and smoking habits were recorded. Nutritional habits were assessed using a semi-
quantitative food-frequency questionnaire and macronutrient consumption was evaluated.
Results: Multi-adjusted analysis after adjustment for various confounding factors revealed that
in patients with first coronary event, plant protein intake at the third quartile of consumption was
associated with 60% (95%CI:0.17-0.95) lower likelihood of developing LVSD, compared to the
first. Furthermore in patients with previous coronary heart disease history, animal protein intake
at the highest quartile of consumption, was associated with 211% greater likelihood of
developing LVSD (95%CI:1.08-8.98), compared to the first.
Conclusions: Plant protein consumption seems to be beneficial, while animal protein consump-
tion detrimental, against the development of LVSD in post-ACS patients.
P331
Dietary intake of vitamin B6, B12 and folate and their association with homocysteine
in adult Polish population
A Waskiewicz, E Sygnowska, G Broda, W Drygas
National Institute of Cardiology, Warsaw, Poland
Topic: Nutrition
WOBASZ investigators
Purpose: To assess vitamin B6, B12 and folate intake and describe the relationship of these
vitamins with homocysteine (Hcy) level in the Polish population.
Methods: Within the frame of the National Multicenter Health Survey (WOBASZ), a repre-
sentative sample of whole Polish population aged 20-74 was screened in years 2003-2005. In
each province of Poland 6 communities were randomly selected and in each of them a sample of
100 men and 100 women from personal identification number (PESEL) database was randomly
selected. In 50% of subjects sample (3004 men and 3401 women) Hcy level and nutrients were
performed according to study protocol.
Results: Average intake of vitamin B6 ranged from 2,26 in men to 2,03 mg/day in women, of
vitamin B12 from 5,85 to 3,69 c¸g/day and folate from 258 to 211 c¸g/day respectively. The
recommended levels of intake were not achieved by 16% of men and 36% of women for vitamin
B6, by 32% and 51% for vitamin B12 and by 78 % and 90% for folate respectively. Hcy level
(after adiustment for age, smoking, coffee and alcohol consumption) and prevalence of hiperHcy
(Hcy =12 c¸mol/l) was falling with an increase of number of quartiles vitamins B6, B12 in both
genders and folate in men. In multivariable linear regression model an inverse association
between Hcy level and intake of vitamin B6 and folate in both genders and vitamin B12 in men
was confirmed.
Conclusions: In Polish population insufficient folate intake was common (deficiency was noted
in nearly 80-90% of population) and despite correct average, high share of subjects were not
fulfilling B6 and B12 intake recommendations; the inverse association between vitamin B6, B12
and folate consumption and Hcy concentration and prevalence of hiperHcy were observed.
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Moderate coffee consumption lowers the likelihood of developing left ventricular
systolic dysfunction in post-acute coronary syndrome normotensive patients
CM Kastorini1, C Chrysohoou2, D B Demosthenes BPanagiotakos1, P Aggelopoulos2,
C Liontou2, C Pitsavos2, C Stefanadis2
1Harokopio University, Athens, Greece, 2Hippokration Hospital, 1st Department of Cardiology of
the University of Athens, Athens, Greece
Topic: Nutrition
Background & Aims: The aim of the present work was to evaluate the association between
coffee consumption and the development of left ventricular systolic dysfunction (LVSD) in
patients who had had an acute coronary syndrome.
Methods: During 20062007, 144 male (6514 years) and 50 female (7112 years) post-acute
coronary syndrome patients who developed LVSD (ejection fraction >40%) after the cardiac
event and 129 male (6412 years) and 51 female (6710 years) post-acute coronary syndrome
patients without LVSD (ejection fraction >50%) were included in the study. Detailed
information regarding their medical records, sociodemographic and anthropometric data, and
various psychological and lifestyle characteristics (physical activity, smoking habits, etc.) were
recorded. In particular, nutritional habits, including coffee consumption, were evaluated using a
semiquantitative food-frequency questionnaire.
Results:Multiadjusted analysis revealed that in normotensive patients coffee consumption of 12
cups/day was associated with 88% (95% confidence interval, 0.020.84) lower likelihood of
developing LVSD and consumption of >3 cups/day with 90% (95% confidence interval,
0.010.88) lower likelihood for LVSD, compared with no history of consumption of coffee
and after adjusting for various confounders. In contrast, in hypertensive patients coffee
consumption of >3 cups/day was associated with 4.5-fold higher likelihood for developing
LVSD (95% confidence interval, 0.8922.58) as compared with no history of coffee consumption.
Conclusions:Coffee consumption has opposite effects on the likelihood of developing LVSD in
post-acute coronary syndrome patients depending on their blood pressure levels.
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Time to update recommendations on the Mediterranean eating style
S Giampaoli1, L Palmieri1, C Donfrancecso1, C Lo Noce1, F Dima1, J Stamler2
1Istituto Superiore di Sanita, Rome, Italy, 2Northwestern University, Feinberg School of
Medicine, Chicago, United States of America
Topic: Nutrition
In 1975 Ancel and Margaret Keys described the Mediterranean eating style in their book, How
to Eat Well and Stay Well The Mediterranean Way:‘‘the ordinary food of the common
Neapolitans – home made minestrone (vegetable soup); pasta in endless variety, always freshly
cooked, served with tomato sauce and a sprinkle of cheese, only occasionally enriched with some
bits of meat, or served with a local sea food without any cheese; beans and short lengths of
macaroni; lots of breadnever served with any kind of spread; great quantities of fresh vegetables;
a modest portion of meat or fish twice a week; wine; always fresh fruits for dessert’’ Today this
eating style is still the keystone of the Mediterranean way. The Keys book also briefly
mentioned potential problems: already in 1975, weight gain – and the issue of energy intake,
including from foods high in favorable fats; excess wine intake by men; high salt; increasing
intakes of meats, sweets. Since 1975 changes have occurred in Mediterranean countries:
industrialization with migration from rural to urban areas; more sedentary work, little physical
exercise during leisure; expanded food supply with modifications in diet composition –
increased proportions of proteins and fats of animal origin compared to those of vegetable
origin; more sugars (e.g. from soft drinks), more salt (from processed foods), less fiber, vitamins,
minerals; caloric imbalance from energy-dense foods and reduced caloric expenditure, respon-
sible for epidemic obesity and aggravating risks of major cardiovascular diseases and cancers.
There is need to reverse these departures from the Mediterranean eating style, and also to note
and overcome its weak points. This is important for a Mediterranean country like Italy, where
stroke death rates are twice those of the USA (despite lower CHD rates). Thus, need for dietary
sodium intake is 10-20 mmol/day, i.e. 0.5-1.0 gr of NaCl/day. Results of the DASH-Sodium
feeding trial are relevant: limited sodium consumption (1.5 gr/day equivalent to 67 mmol/l)
along with high intake of fruits and vegetables, whole grains, legumes, low fat and fat free dairy
products, fish, poultry; limited in red meat, visible fats, eggs, sweets – effective for reduction of
blood pressure and serum lipids in the general population. This is a food pattern like the
Mediterranean eating style.
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Seleniumdeficiency is associatedwith adverse vascular function in patientswith high
risk for vascular events
YH Chan1, CW Siu1, KH Yiu2, HT Chan1, SW Li3, CP Lau1, TH Lam1, HF Tse1
1The University of Hong Kong, Hong Kong, People’s Republic of China, 2Queen Mary Hospital,
Department of Medicine, Hong Kong, Hong Kong SAR, People’s Republic of China 3Tung Wah
Hospital, Hong Kong, People’s Republic of China
Topic: Nutrition
Background: Experimental studies have shown that selenium is involved in the synthesis of
selenoproteins relevant to the protection against cardiovascular disease. However, the relation-
ship between selenium deficiency and vascular function in clinical context remains unknown.
Methods:We studied 306 consecutive patients with high risk for vascular events (coronary artery
disease 35%, acute/ recurrent ischemic stroke 40%, diabetes 58%). Non-invasive brachial-ankle
pulse wave velocity (baPWV) was measured using vascular profiling system (VP-2000). Long-
term intake of selenium was determined by a validated food frequency questionnaire.
Results: Mean daily selenium intake was 59.4  52.1 mcg/day. Mean baPWV was 1782.4 
418.4 m/s indicating increased arterial stiffness overall. Patients with selenium intake <10th
percentile had significantly higher baPWV as compared to patients with intake ? 10th percentile
(1994.4  662.6 m/s versus 1761.0  380.8 m/s, P¼0.005). After adjusting for potential
confounders including age, gender, history of hypertension, hyperlipidemia, diabetes and
cardiovascular disease, smoking status, use of cardiovascular medications, waist-hip ratio,
education/ financial status, physical activity, calorie intake and intake of antioxidant vitamins,
deficient selenium intake <10th percentile remained independently predictive of increased
baPWV by 768.5 m/s [95% CI: 1345.0-192.0 m/s, P¼0.010].
Conclusion: Selenium deficiency is associated with worsening arterial stiffness in patients with
high risk for vascular events.
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Rural to urban migration in India increases obesity and diabetes risk
S B J Ebrahim1, S Kinra1, L Bowen1, L Andersen1, Y Ben-Shlomo2, T Lyngdoh3, D
Prabhakaran4, K,S Reddy3
1London School of Hygiene and Tropical Medicine, London, United Kingdom, 2University of
Bristol, Bristol, United Kingdom, 3Public Health Foundation of India, New Delhi, India, 4Centre
for Chronic Disease Control, New Delhi, India
Topic: Obesity
Indian Migration Study
Background: Effects of migration on risk of obesity and diabetes cannot be reliably assessed
from simple rural urban comparisons. We hypothesised that rural to urban migrants would be at
higher risk of obesity and diabetes than rural non-migrants and that migrants would have an
intermediate risk of obesity and diabetes compared with life-long urban and rural dwellers using
a sib-pair design.
Methods:The place of origin of people working in factories in north, central and south India was
identified. Migrants of rural origin, their rural dwelling sibs, those of urban origin and their urban
dwelling sibs were assessed by interview, examination and fasting blood samples. Obesity,
diabetes and other cardiovascular risk factors were compared.
Results: A total of 6,510 participants (42% women) were recruited. Among urban, migrant and
rural men the age and factory adjusted percentages classified as obese (BMI 25þkg/m2) were
41.9%, 37.8%, and 19.0% respectively and diabetic were 13.5%, 14.3%, and 6.2% respectively.
Findings for women showed similar patterns, but prevalence of obesity was higher and of
diabetes was slightly lower than in men. Rural men had lower blood pressure, lipids and fasting
blood glucose than urban and migrant men, whereas no differences were seen in women.
Conclusion: Migration is associated with increases in obesity which drive other risk factor
changes. Migrants are at higher risk of obesity and diabetes than rural dwellers, but have adopted
lifestyles putting them at similar risk to the urban population. Gender differences in some risk
factors by place of origin are unexpected and require further exploration.
Migration status: obesity and diabetes
Men Women
Urban Migrants Rural p for
trenda
Urban Migrants Rural p for
trenda
Obese 4.32
[3.34,5.59]
3.63
[2.85,4.62]
1 <0.0001 4.98
[3.65,6.79]
4.11
[3.08,5.50]
1 <0.0001
Diabetic 2.74
[1.97,3.81]
2.58
[1.87, 3.56]
1 <0.0001 2.76
[1.64,4.66]
2.70
[1.64,4.45]
1 <0.0001
Odds ratios (95% CI) for the risk of disease in a sibling compared to a rural sibling, adjusted for
age group and factory.
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12-month weight loss and triglyceride changes with PHEN/TPM in overweight and
obese subjects with hypertriglyceridemia
K Gadde1, C Peterson2, B Troupin2, WW Day2
1Duke University Medical Center, Durham, United States of America, 2VIVUS, Inc, Mountain
View, United States of America
Topic: Obesity
The CONQUER Study Team
Background: PHEN/TPM is a low-dose, controlled-release combination of phentermine
(PHEN) and topiramate (TPM) for once-daily oral dosing. This phase 3 study evaluated
weight loss over a 56 week period in overweight and obese subjects with two or more co-
morbidities.
Methods: In this double-blind, placebo-controlled trial, 2487 subjects were randomly assigned
to one of 2 dose levels of PHEN/TPM (15/92 and 7.5/46 mg) or placebo. All subjects were
managed to standard of care for their dyslipidemia, received lifestyle and exercise guidance, and
were instructed on a 500 kcal/day deficit diet. Subjects were seen at monthly clinic visits, and
had periodic fasting laboratory assessments.
Results: The majority of the 2487 subjects randomized to study treatment were female (70%)
and Caucasian (86%). Subjects averaged 51 years of age, with a baseline mean weight of 103.1 kg,
mean BMI of 36.6 kg/m2, and mean fasting triglycerides of 162.5 mg/dL (1.84 mmol/L). 36% of
enrolled subjects were considered hypertriglyceridemic. Mean weight loss at 56 weeks was
1.8%, 8.4%, and 10.4% (ITT-LOCF); and in subjects completing the entire 56 weeks of
treatment on study drug, mean weight loss at Week 56 was 2.4%, 10.5%, and 13.2% for the
placebo, 7.5/46 mg, and 15/92 mg groups, respectively (p<0.0001). Subjects with hypertrigly-
ceridemia showed comparable weight loss at Week 56. The mean percent change in fasting
triglycerides from baseline at Week 56 for the entire study population was a decrease of 11.3 to
13.3% compared to a 1.8% increase in placebo (p<0.001 for PHEN/TPM and 0.005 for placebo).
For subjects with hypertriglyceridemia (baseline TG 233 mg/dL, 2.63 mmol/L), the mean
percent change in fasting triglycerides at Week 56 with LOCF was9.4% with placebo,23.7%
with PHEN/TPM 7.5/46 mg, and 25.2% with PHEN/TPM 15/92 mg treatment. Additional
lipid parameters will be discussed during the session.
Conclusions: In this large, randomized, controlled clinical trial, significant weight loss and
clinically meaningful improvements in lipid parameters were seen over 56 weeks of treatment
with both doses of PHEN/TPM compared to placebo. Well-tolerated medical treatments that
effect significant weight reduction and can address common obesity-related co-morbidities may
have significant benefits in terms of preventing future weight-related morbidity and mortality.
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Prevalence of metabolically healthy obesity in a Swiss population-based cohort
S Velho1, P Marques-Vidal1, F Paccaud1, G Waeber2, P Vollenweider2
1University Institute of Social and Preventive Medicine Lausanne (IUMSP), Lausanne, Switzer-
land, 2University Hospital Center Vaudois, Lausanne, Switzerland
Topic: Obesity
Objective: To assess the prevalence of metabolically healthy obesity (MHO) in the Swiss
population according to different definitions.
Methods: population-based sample of 2803 women and 2557 men. Metabolic abnormalities
were defined using two sets of criteria: elevated blood pressure, triglycerides, fasting glucose,
high-sensitivity C-reactive protein and homeostasis model assessment (HOMA), and low high
density lipoprotein (HDL) cholesterol (set 1); elevated total cholesterol, low density lipoprotein
cholesterol and HOMA index, and low HDL cholesterol (set 2). For each set, prevalence of
MHO was assessed for three obesity markers (body mass index, waist circumference or body fat).
Results: Among obese (BMI=30 kg/m2) participants, prevalence of MHO was 18.8% and 7.3%
using sets 1 and 2, respectively (3.1% and 1.2% in the general population). Conversely, the
prevalences of MHO using sets 1 and 2 were 27.2% and 9.6% when using waist, and 19.6% and
6.4% when using body fat. Prevalence of MHO was higher in women than in men (21.8% vs.
15.8%, for BMI and set 1). After multivariate adjustment, a lower odds of presenting with MHO
was found in men: OR¼0.59, 95% confidence interval (0.49-0.70); with increasing age: OR¼0.59
(0.47-0.73), 0.31 (0.25-0.39) and 0.24 (0.19-0.31) relative to age group 35-44 for age groups 45-54,
55-64 and 65-74 years, respectively; and smoking status: OR¼0.83 (0.69-1.00) and 0.80 (0.65-
0.98) for former and current smokers, respectively. Conversely, higher odds of MHO were found
for moderate alcohol consumption: OR¼1.32 (1.07-1.61), 1.35 (1.06-1.71) and 0.98 (0.75-1.26)
relative to nondrinkers, for 1-6, 7-13 and >13 drinks/week, respectively; and leisure-time
physical activity, OR¼1.51 (1.29-1.77). Finally, obese women presented with significantly
higher hs-CRP levels and with lower hypertension, hypertriglyceridaemia and hyperglycaemia
prevalence than obese men.
Conclusion: The prevalence of MHO varies considerably according to the definition used.
Between-gender differences in the prevalence of the metabolic abnormalities, suggest the need
for gender-specific, standardized, agreed upon, MHO criteria.
P338
Effects of an in-patient lifestyle programme for overweight and obese children
M Rank1, M Siegrist1, H Langhof2, B Wolfarth1, W Koenig3, M Halle1
1Technical University of Munich, Munich, Germany, 2Clinic Schoensicht, Berchtesgaden, Germany,
3University of Ulm, Ulm, Germany
Topic: Obesity
Purpose: Plasma concentration of leptin, an adipokine secreted by adipocytes, is increased in
overweight and obese children. It acts as a satiety hormone and links fat mass to food intake and
energy expenditure. Furthermore obesity is characterized by a state of low-grade inflammation
at all ages. Little is known on the effects of short-term therapy programmes on the relationship
between changes in body composition and plasma concentrations of leptin and inflammatory
markers in overweight and obese children additionally focusing on changes in exercise capacity.
Methods: Between 2006 and 2008 we examined 498 overweight and obese children and
adolescents (301 girls, 211 boys, age 8-18 years) before and after a 4 week in-patient treatment
programme including nutritional counseling, increase in physical activity and behavioral
intervention. During the pre- and post-intervention examinations, anthropometric data, plasma
concentration of leptin, IL-6 and TNF-a were assessed. The cardiovascular fitness was
determined by a cardiopulmonary maximal bicycle-ergometer stress test.
Results: Over the 4 week intervention we found a significant reduction in body weight from
91.023.1 kg to 84.021.4 kg (p<0.001). Leptin levels decreased significantly from 39.5  24.5
ng/dl to 18.614.4 ng/dl (p<0.001). In addition, we found an increase in relative exercise
capacity from 1.660.40 to 2.040.48 W/kg (p<0.001). Concentrations of IL-6 and TNF-a
remained unchanged. Correlation analyses between reduction in body weight and the reduction
in leptin concentrations were significant (p < 0.001), whereas the increase of relative exercise
capacity was not associated with changes in leptin (p ¼ 0.428).
Conclusion: A life-style programme significantly improves body weight as well as exercise
capacity and induces a reduction in plasma leptin concentration in overweight and obese
children. The changes in leptin are dependent on changes in body weight but not on changes in
physical exercise capacity. Leptin therefore seems to be independent of exercise capacity.
P339
Trends in overweight and diet among Russian adolescent population
D Denisova, L Zavyalova, M Voevoda
Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences,
Novosibirsk, Russian Federation
Topic: Obesity
Rising of children and adolescent obesity in recent decades was well documented worldwide,
but there is a lack of information about Russian young population.
Objective: Using international references the trends of overweight and nutrition in adolescent
population aged 14-17 y during 1989-2009 in Russia were examined.
Design: Five cross-sectional surveys of representative samples of school children aged 14-17 in
1989, 1994, 1999, 2003 and 2009 were carried out. Total sample was 3060 (45% males). To define
overweight the sex- and age-specific body mass index (BMI) cutoffs recommended by the
International Obesity Task Force were used. Diet was estimated using 24-hour dietary recall.
The questionnaire for parents with the information on self-reported height and weight was used.
Results: The prevalence of overweight significantly decreased from 12% in boys and from 14%
in girls in 1989 to 4% in 1999 for both gender groups. Since 2003 slight increasing of overweight
was observed among both genders particularly in boys. During the same period (1989-1999)
significant decreasing of total energy intake (from 3021 to 2342 kcal in boys and from 2300 to
1644 kcal in girls) and of basic nutrient intakes (proteins, fats, carbohydrates) was registered.
From 2003 to 2009 there was moderate rising of nutrient intakes among adolescents. In spite of
concordant trends of overweight and energy consumption there were not associations between
BMI and dietary factors in observed population. Associations of parents and children s BMI
levels were revealed. Parents of overweight adolescents had BMI higher than parents of
adolescents with normal BMI.
Conclusion: Revealed decreasing of overweight rates among Russian adolescent population
during the period of socioeconomic crisis following by changes in diet indicate on significant
influences of reforms on life style and some health parameters in children.
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Supervised exercise training benefit on physical fitness in youngmetabolic syndrome
patients
C Avram1, M Oravitan1, LD Hoble1, E Bota1, S Voicu1, D Gaita2
1West University Timisoara, Timisoara, Romania, 2Victor Babes University of Medicine and
Pharmacy, Timisoara, Romania
Topic: Obesity
Metabolic syndrome (MS) consists of multiple, interrelated risk factors of metabolic origin that
appear to directly promote the development of atherosclerotic cardiovascular disease or diabetes
mellitus. An important role in MS treatment is played by the lifestyle management including
increase in physical fitness.
Purpose: To evaluate the exercise training benefit in young metabolic syndrome patients.
Methods: We conduct a randomized prospective study of 6 months on 94 voluntary students,
previously diagnosed with MS usingNational Cholesterol Education Program Adult Treatment
Panel III criteria. The patients were divided in 2 groups: Group S (43 patients) benefit from an
intensive exercise training programme supervised and guided by a personal trainer; Group C: 51
patients had the same exercise training recommendations but were unsupervised. All patients
were evaluate through a cardiopulmonary exercise testing (CPET) at inclusion and after 6
months. The CPET results were used to prescribe the optimal effort intensity of the exercise
training programme in order to improve endurance and increase the VO2peak. Exercise
recommendation consisted in 3 times per week of 60 minutes at extensive and intensive
endurance training zone (in the range of anaerobic threshold), completed by 1 minute interval in
the range between anaerobic threshold (AT) and respiratory compensation point (RCP), for
every 5 minutes of training.
Results: The 6 months follow-up of the Group S showed a significant improvement in physical
fitness: Oxygen uptake (VO2) at AT increased from 1.19 to 1.55 L/min, P<0.0001; VO2 at RCP
increased from1.66 to 1.96 L/min, P¼0.0003 and VO2peak increased from1.9 to 2.13 L/
min,P<0.0001. We also noticed an increase of the oxygen pulse (VO2/HR an important indices
of cardiac performance in exercise) from 10.3 to 11.7 mL, P<0.0001. Even there were no
significant differences between groups at baseline, the comparison at the end of the study
showed the additional benefit of the Group S patients, which was intensively supervised.
Conclusions: Six months supervised exercise training programme improves physical fitness in
young metabolic syndrome patients. The study is a clear demonstration that using sports
technology and close supervision of the exercise programme, we can obtain an additional benefit
on physical fitness than recommendations alone. This particular intensive intervention is
recommended at least in the beginning of a lifestyle changing programme.
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Metabolic syndrome is associated with a higher prevalence of nonalcoholic fatty liver
disease
Y Cavusoglu, A Cavusoglu, I Unluoglu, M Unalacak, M Tek, C Demirustu, F Yuksel,
N Ata
Eskisehir Osmangazi University, Eskisehir, Turkey
Topic: Obesity
Purpose: The metabolic syndrome (MS) in adults is associated with an increased risk for
development of type 2 diabetes and cardiovascular disease. Obesity and elevated fasting
triglyceride levels, which are the components of MS, have also been shown to be more tightly
correlated with nonalcoholic fatty liver disease (NAFLD). However,the frequencyof NAFLD in
MS is not clear. Therefore, the aim of this study was to determine whether evidence of NAFLD
were more common in patients with MS than in those without MS.
Methods: A total of 251 consecutive subjects were enrolled in the study. A blood sample was
obtained for fasting glucose, lipid panel as well as alanine aminotransferase (ALT), aspartate
aminotransferase (AST) and gamma-glutamyl transpeptidase (GGT) to determine the presence
of markers for NAFLD. Additional liver ultrasound (US) was performed to evaluate the
presence of fatty liver. MS was defined by ATP III criteria (3 or more of the following
abnormalities): waist circumference >102 cm in men and >88 cm in women; triglycerides
(TG) >150 mg/dl; high-density lipoprotein cholesterol (HDL-C) < 40 mg/dl in men and <50
mg/dl in women; blood pressure >130/85 mmHg; or fasting glucose level >100 mg/dl. Patients
with any etiology for abnormal liver function tests such as chronic hepatic or renal disease,
alcohol use, hepatotoxic drug use, hepatitis B or C positivity, connective tissue diseases were
excluded from the study.
Results: In the study population 67 subjects had 3 or more MS criteria (MS group) and the
remaining 184 did not (control group). Mean age was not different between groups with and
without MS (468 vs 479 years, p¼ns). As has been expected, waist circumference (1038 vs
9510 cm, p<0.001), TG (21786 vs 12361 mg/dl, p<0.001), fasting glucose (10436 vs
8512 mg/dl, p<0.001) were higher and HDL-C (4110 vs 5212 mg/dl, p<0.001) was lower in
MS group compared with the control group. Mean ALT (31.023.0 vs 22.615.2 IU/L,
p¼0.001), AST (23.410.3 vs 20.97.6 IU/L, p¼0.038) and GGT (32.323.6 vs 23.719.0
IU/L, p¼0.004) levels were found to be significantly higher in MS group than in control group.
The proportion of subjects with transaminase levels more than the upper limit of normal was also
higher in MS group as compared to control group (%20.9 vs %8.6, p¼0.01 for ALT, %10.4 vs
%3.8, p¼0.047 for AST, %20.9 vs %5.4, p¼0.001 for GGT). Liver US showed steatosis in 78.5%
of subjects with elevated ALT and AST or GGT.
Conclusions: This study suggest that the presence of MS was associated with a significantly
higher prevelance of markers for NAFLD and an increase in fatty liver on US.
P342
Physical and psychological aspects of obesity in Lithuanian urban population of
Kaunas city
M Baceviciene, D Luksiene, A Tamosiunas, R Reklaitiene, E Daugeliene, R Radisaus-
kas
Institute of Cardiology, Kaunas, Lithuania
Topic: Obesity
Purpose: The aim of the study was to evaluate physical and psychological aspects of obesity in
urban Lithuanian population of Kaunas city.
Methods: Random sample of 7115 men and women, aged 45-72, stratified by age and sex was
selected from the population register of Kaunas city. Response rate was 60.5%. Health
examination as a part of international HAPIEE (Health, Alcohol and Psychosocial factors In
Eastern Europe) study was carried out in 2006-2008. Examination included physical measure-
ments and information on risk factors related to lifestyle. 1193 respondents were randomly
selected to fill in the WHOQOL-100 questionnaire. The relationship between body mass index
(BMI) and life-style related risk factors, objective measurements, overall quality of life (QOL),
aspects of energy and fatigue, body image and appearance, mobility, daily activities and
dependence on medication were analyzed using age-adjusted general linear models.
Results: 78% of men and 81% of women had excess body weight. Mean systolic and diastolic
blood pressure was found to be higher in obese respondents group as compared to the group of fit
weight (p<0.01). Obese people had higher levels of fasting blood glucose, triglycerides and low
density lipoproteins; whereas high density lipoprotein cholesterol level was lower among obese
respondents (p<0.001). Obese women consumed less amounts of alcohol (p<0.05) whereas
smoking was more prevalent among obese men (p<0.01) as compared to the groups of normal
body mass. Mean amount of hours that were spent for physical activity a week was higher in
women with BMI<25.0 kg/m2 as compared to obese women (22.0 and 18.2, p<0.05). Con-
versely, obese people were tended to follow healthier diet of higher amounts of fresh fruit and
vegetables and lower amounts of sweets (p<0.05). When controlling effect of age, mean scores of
energy and fatigue, daily activity, dependence on medication, mobility facets and overall QOL
were lower in obese respondents as compared to the ones with normal body mass (p<0.05).
Obese men and women were less satisfied with their body appearance as compared to the ones
with fit body weight (men 67.1 and 69.6, women 58.0 and 68.2 respectively, p<0.05). Obese and
overweight women more often rated their health as bad or very bad as compared to women with
BMI<25.0 kg/m2 (p<0.05).
In conclusion, high prevalence of obesity in Lithuanian urban population should receive more
attention of health policy as a factor predicting poor subjective status and related to large number
of conditions linked to reduced objective physical statement.
P343
Effects of physical training on cardiac modulation in normal weight, overweight, and
obese individuals: a comparative study
H C Hugo CelsoDutra De Souza, THR Di Sacco, IC Cozza, KD Maida
University of Sao Paulo, Ribeirao Preto, Brazil
Topic: Obesity
Purpose: Our study has assessed the effect of aerobic physical training on the heart rate
variability (HRV) on sedentary women with different body mass indices (BMI; weight/height˙).
Methods: Forty-eight volunteers were divided into three groups according to their BMI as
follows: NW group (normal weight), 18.0-24.9; OW group (overweight), 25.0-29.9; and OB group
(obese), 30.0-39.9. All the subjects were submitted to aerobic physical training protocol during
12 weeks. HRV was assessed with the subjects at rest and during tilt test by means of spectral
analysis.
Results: Prior to aerobic physical training, OW and OB groups exhibited decrease in low
frequencies (LF, 0.40.15 Hz) and high frequencies (HF, 0.15-0.5 Hz). After APT, NW, OW, and
OB groups had similar HF oscillations, with only OB group exhibiting increase in LF
oscillations. The HRV responses to tilt test obtained before and after aerobic physical training
showed that NW group had no differences in LF (34  6% vs. 36  8%) and HF (65  6% vs.
60 7%) oscillations. However, OW group had an increase in LF (46 6% vs. 86  14%) and
HF (44 7% vs.61  7%) oscillations, whereas OB group had a decrease in LF (288  25%
vs. 159  16%) and HF (83  5 vs. 70  4%) oscillations.
Conclusion: Our results suggest that regular physical activity has a beneficial effect on the
autonomic nervous system, thus being a relevant predictor of cardiovascular morbidity and
mortality, and that physical training can attenuate the negative effect of obesity.
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Nutrient intake in relation to central and overall obesity status among elderly people
living in mediterranean islands: the MEDIS study
S Tyrovolas1, T Psaltopoulou2, G Pounis1, N Papairakleous1, V Bountziouka1, A
Zeimbekis3, E Gotsis1, M Antonopoulou4, G Metallinos1, E Polychronopoulos1, C
Lionis1, DB Panagiotakos1
1Harokopio University, Athens, Greece, 2Department of Hygiene, Epidemiology, and Medical
Statistics, School of Medicine, University of Athen, Athens, Greece, 3Health Center of Kalloni,
General Hospital of Mitilini, Mitilini, Greece, 4University of Crete, Medical School, Clinic of
Social and Family Medicine, Heraklion, Greece
Topic: Obesity
Background: Obesity becomes a global epidemic throughout the developed world. The aim of
the present work was to evaluate the relationship between energy-generating nutrients and the
presence of central and overall obesity after correcting for socio-demographic, lifestyle and
clinical characteristics, among healthy elders.
Methods: During 2005-2007, 553 elderly men and 637 elderly women (mean age 747 years)
from eight Mediterranean Islands in Greece and Cyprus, were enrolled. The retrieved
information included demographic, bio-clinical and dietary characteristics. MedDietScore
assessed adherence to the Mediterranean dietary pattern.
Results: The prevalence of obesity was 27% in males and 39% in females (p<0.001), while 73%
of males and 87% of females had central obesity. The obese elderly presented higher
consumption of carbohydrates (p<0.001) and lower consumption of fat (p¼0.006) After
adjusting for various confounders, one percent increase in carbohydrate consumption was
associated with 12% (95%CI 0.78-0.99) lower likelihood of having central obesity, while one
percent increase in carbohydrate and protein consumption was associated with 14% (95%CI
0.78-0.95) and 16% (95%CI 0.72-0.97) lower likelihood of being obese, respectively. Vegetable
protein was found to be associated with 15% (95%CI 0.77-0.93) lower likelihood of being obese
while, only low glycemic index carbohydrates seem to be associated with a 6% (95%CI 0.90-0.98)
lower likelihood of having central obesity.
Conclusions: The presented findings suggest that a diet high in carbohydrates and vegetable
protein is associated with lower likelihood of being obese and may help the elderly persons to
preserve normal weight.
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The healthy knowledge of obese persons, do they know more about cardiovascular
diseases prevention? Results of WOBASZ Study
A Piwonska, E Sygnowska, W Drygas
Institute of Cardiology, Warsaw, Poland
Topic: Obesity
WOBASZ group
Purpose:Obesity is one of main risk factors (RF) of CVD morbidity and mortality, because many
proven CVD risk factors, like f. e. hypertension, lipid disturbances, diabetes, are strongly
associated with obesity. It is also a huge healthy problem in many populations. To have an
effective prevention programs one should know the healthy knowledge of population. We want
to evaluate the healthy knowledge [on own RF, complications of untreated hypertension (cHT)
and prevention methods (PM)] of obese persons and we want to know if it is greater than the
knowledge of the rest of population.
Methods: Data came from representative Polish population sample - 6392 men and 7153
women, aged 20-74, examined in 2003-2005 in the frame of Polish National Health Survey
(WOBASZ). Data on socio-demographic factors, healthy knowledge were assessed using
questionnaire and collected together with data from biochemistry and physical examination.
We analyzed the frequency of persons that know their body mass (BM), can correctly classified it
to the group of overweight or obesity, know their blood pressure (BP), cHT and MP.
Results: 1313 men - M (21%) and 1612 women - W (22%) were obese. Obese persons were older
and independently of age had higher levels of RF. Out of obese persons, 8% of men and 18% of
women did not know their own BM, and 30% of men and 25% of women did know their own BP.
About 50% both obese, as well as not obese men, could give their BM exactly to the 2 kg, but
obese women rarely than the others knew their BM. Obese persons more often than not obese
correctly classified their BM. Persons with obesity had significantly better knowledge on own BP
and on classification of BP to normal/low or high group. Moreover obese persons (especially
men) better knew cHT. About 30% of obese men and women (less than in population with
normal weight) did not know any cHT. The knowledge on PM was worse among obese persons
or did not differ significantly In comparison to the rest of population. More than 30% of obese
persons did not know any PM.
Conclusions: Obese persons were characterized by better, than the rest of population, knowl-
edge on own risk factors or complications of untreated hypertension, but worse knowledge on
prevention methods.
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Adherence with statins in a real-life setting is better when cardiovascular risk factors
increase
T Coufﬁnhal1, P Latry2, M Molimar3, B Begaud3, M Laﬁtte1, K Martin-Latry3
1University Hospital of Bordeaux - Hospital Haut Leveque, Departement of Cardiology, Pessac,
France, 2Direction Regionale du Service Medical de l’Assurance Maladie d’Aquitaine, CNAM-
TS, Bordeaux, France, 3Inserm U 657, Universite Victor Segalen Bordeaux 2, Bordeaux, France
Topic: Pharmacoepidemiology
Background: Several studies have shown poor adherence to statin treatments and several
associated factors have been highlighted: younger age, insufficient revenue, absence of cardi-
ovascular morbidity, women, number of coprescribed drugs. While the factors for poor adher-
ence have been highlighted, the impact of their combination on adherence is not clear.
Purpose: To estimate adherence for statins and whether it differs according to the number of
cardiovascular risk factors.
Methods: A cohort study was conducted using data from the French social security insurance
database. Patients were included if they submitted a reimbursement form for a prescription for
statins between September 1 and December 31, 2004, and did not receive any statin treatment
for 6 months previous to this. Patients were followed up 15 months. Statin use was considered a
proxy for hypercholesterolemia. The cohort was split into three groups according to their
number of additional cardiovascular risk factors that included age and gender, diabetes mellitus
and cardiovascular disease (using co-medications as a proxy). Adherence was assessed for each
group by using four parameters: (i) proportion of days covered by statins, (ii) regularity of the
treatment over time, (iii) persistence, and (iv) the patient s understanding of the treatment.
Results: 16,397 newly treated patients were identified. Of these statin users, 21.7 % did not have
additional cardiovascular risk factors. Thirty-one percent had two cardiovascular risk factor and
47 % had at least three risk factors. All the parameters showed a sub-optimal adherence whatever
the group: days covered ranged from 56 % to 72 %, regularity ranged from 23 % to 33 % and
persistence ranged from 44 % to 59 %, but adherence was better for those with a higher number
of cardiovascular risk factors.
Conclusions: The results confirm that long-term drug treatments are a difficult challenge,
particularly in patients at lower risk.
P347
Atorvastatin worsens glucose metabolism and insulin sensitivity in hypercholester-
olemic patients
K Koh1, Michae Quon2
1Gachon University, Incheon, Republic of Korea 2NIH, Diabetes Unit, Bethesda, United States of
America
Topic: Lipids and atherosclerosis
Background:We hypothesized atorvastatin, particularly at high dose, may increase insulin levels
and worsen glucose metabolism with reducing plasma levels of adiponectin and insulin
sensitivity in hypercholesterolemic patients.
Methods: This was a randomized, single-blind, placebo-controlled, parallel study. Age, sex, and
body mass index were matched. Forty-four patients were given on placebo and 42, 44, 43, and 40
patients were given daily on atorvastatin 10, 20, 40, and 80 mg, respectively during a 2 month
treatment period.
Results: Atorvastatin 10, 20, 40, and 80 mg significantly reduced LDL cholesterol (mean %
changes; 39, 47, 52, and 56%) and apolipoprotein B levels (33, 37, 42, and 46%) after 2 months
therapy when compared with baseline (all P<0.001 by paired t-test) or when compared with
placebo (P<0.001 by ANOVA). Atorvastatin 10, 20, 40, and 80 mg significantly increased insulin
(25, 42, 31, and 45%) and glycated hemoglobin levels (2, 5, 5, and 5%) from baseline (all P<0.05
by paired t-test) or when compared with placebo (P¼0.009 for insulin and P¼0.008 for glycated
hemoglobin by ANOVA). Atorvastatin 10, 20, 40, and 80 mg decreased plasma adiponectin levels
(4, 10, 3, and 9%) and decreased insulin sensitivity (1, 3, 3, and 4%) when compared with
baseline (P¼0.124, P¼0.004, P¼0.084, and P¼0.040 for adiponectin; P¼0.312, P¼0.008,
P<0.001, and P¼0.008 for insulin sensitivity by paired t-test) or when compared with placebo
(P¼0.183 for adiponectin and P¼0.033 for insulin sensitivity by ANOVA). However, the
magnitude of these percent changes (glycated hemoglobin, insulin, adiponectin, and QUICKI)
were not significantly different among the four different doses of atorvastatin despite dose-
dependent changes in LDL cholesterol and apolipoprotein B reduction.
Conclusions: Atorvastatin significantly increased insulin and glycated hemoglobin levels and
reduced insulin sensitivity in hypercholesterolemic patients independent of dosage and the
extent of LDL cholesterol and apolipoprotein B reduction.
P348
Postprandial lipemia in familial combined hyperlipidemia, familial hypercholester-
olemia and healthy subjects
A Pavlidis, G Kolovou, K Anagnostopoulou, P Petrou, K Sorodila, A Valaora, K
Salpea, D Cokkinos
Onassis Cardiac Surgery Center, Athens, Greece
Topic: Lipids and atherosclerosis
Purpose: Familial combined hyperlipidemia (FCH) is the most common familial dyslipidemia
among patients who suffer early myocardial infarction. Familial hypercholesterolemia (FH) is a
monogenic disorder of lipid metabolism secondary to low density lipoprotein receptor mutations
that has been strongly linked to premature coronary artery disease (CAD). Postprandial
hypertriglyceridemia is also associated with CAD. The purpose of this study was to evaluate
postprandial lipemia after an oral fat tolerance test (OFTT) in men with FCH and compare
them to FH and healthy subjects.
Methods:The study population consisted of 83 subjects. OFTT was given to 34 men with FCH,
29 men with FH and 20 healthy men. The FCH and FH groups were further divided according
to the lipid phenotype, on the basis of Fredrickson s classification, into five subgroups: FCH IIA
(n¼13), FCH IIB (n¼10), FCH IV (n¼11), FH IIA (n¼21) and FH IIB (n¼8). TG concen-
trations were measured before, 2, 4, 6 and 8 h after OFTT and the postprandial response was
evaluated by the areas under the curve (AUC) for TG concentrations.
Results: The TG levels after OFTT were significantly higher in FCH compared to FH and
healthy groups (AUC in mg/dl/h; 26781415 vs. 15031147 and 1011652 respectively,
p<0.001). The postprandial TG levels were significantly increased in FCH IV and FCH IIB
groups compared to FCH IIA (AUC in mg/dl/h; 3220824 vs. 3409770 and 1863577
respectively, p<0.001). FCH IIA group demonstrated higher TG levels at 2, 6 and 8h, compared
to FH IIA group (p¼0.05, p¼0.017 and p¼0.013 respectively). There were no significant
differences between FH IIB and FCH IIB subgroups.
Conclusions: FCH and FH patients demonstrate an exaggerated postprandial response, that
could partially contribute to the high cardiovascular risk. This abnormal response is even more
pronounced in FCH subjects with a mixed lipid phenotype. These patients should be identified
early and treated with the appropriate hypolipidemic regime.
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Castelli risk index updated. Correlation between apolipoprotein B/apolipoprotein A1
and total cholesterol/HDL-cholesterol ratios in a healthy population
DA Siniawski, WMMasson, P Sorroche, W Scordo, L Casanas, J Krauss, AM Cagide
1Italian Hospital of Buenos Aires, Buenos Aires, Argentina
Topic: Lipids and atherosclerosis
Background: Total cholesterol/HDL-cholesterol ratio (TC/HDLr) was proposed as a coronary
risk marker approximately 25 years ago by Dr. W. Castelli and the goal suggested was <4.5.
Recent studies demonstrated that apolipoprotein B/apolipoprotein A1 ratio (ApoB/ApoAr) is an
independentcoronary riskpredictor. For various reasons, many patients can not access to
apolipoprotein measurements. Objetives: Determine in a healthy population from Argentina
TC/HDLr values corresponding to the decile 1 of the ApoB/ApoAr (0.43, odds ratio 1.00) in the
INTERHEART study (IH). Suggest updated TC/HDLr goals to improvecoronary riskcateg-
orization and targets in patients with high vascular risk.
Methods: Apolipoprotein levels were measured by kinetic nephelometry in samples obtained
from blood givers. Correlations between ApoB/ApoAr and TC/HDLr were assessed. Two linear
regression analyses models were performed for ApoB/ApoAr versus TC/HDLr: in the total
population and in the very low risk subpopulation (sP) composed of non-smoking subjects with a
body mass index <25. ROC analysis was done to assess the accuracy of the Castelli index to
discriminate between subjets with ApoB/ApoAr > or =0.43.People with diabetes, hypertension,
cardiovascular disease, or receiving lipid-lowering drugs were excluded.
Results: 283 subjets were included. Men: 64%, smokers: 31%, with ApoB/ApoAr >0.43: 82%.
General characteristics (meanSD): age: 4214 years, BMI 264, TC 19940 mg/dL, HDL-C:
4913 mg/dL, TC/HDLr: 4.311.28, ApoB: 95.228 mg/dL, ApoA: 157.631 mg/dL, ApoB/
ApoAr: 0.620.21. Correlations between ApoB/ApoAr and TC/HDLr in the total population and
sP were: 0.90 and 0.91 respectively. In the lineal regression models ApoB/ApoAr value of 0.43
(decile 1 of IH) corresponded to a TC/HDLr of 3.22 and 3.17 in the total population and sP
respectively. The AUC for the TC/HDLr for detecting an ApoB/ApoAr >0.43 was 0.936 (95%
CI 0.897-0.975) and the optimal cut-off point 3.24 (sensitivity 91%, specificity 84%, positive
predictive value 96%, negative predictive value 68%).
Conclusions: These results suggest that the Castelli index goal <4.5 should be revised and
updated to<3.2. This target resembles the TC/HDLr observed in the decile 1 of the IH study.
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Lipid profile of Spanish patients with coronary heart disease treated with statins.
Dyslipidemia International Study (DYSIS-SPAIN)
JR Gonzalez-Juanatey1, C Guijarro2, E Alegria3, JV Lozano4, B Gonzalez-Timon5, E
Gomez-Salinas5, G Vitale5, J Millan6
1University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain,
2Hospital Fundaciœn Alcorcœn, Madrid, Spain, 3University Clinic of Navarra, Pamplona,
Spain, 4Health Centre Serreria 2, Valencia, Spain, 5Merck Sharp Dohme, Madrid, Spain
6University Hospital General Gregorio Maranon, Madrid, Spain
Topic: Lipids and atherosclerosis
Introduction: LDL-C is the therapeutic target for cardiovascular prevention and the NCEP
ATP III guidelines recommend statins to reduce LDL-C levels. Patients with coronary heart
disease (CHD) are considered as high cardiovascular risk; therefore they have a lower LDL-C
target. Some studies have found that low HDL-C and high triglycerides (TGs) may have a role in
coronary risk but statins have limited action on them. The aim of this analysis was to describe the
lipid profile of Spanish statin-treated patients with coronary heart disease (CHD).
Methods: Analysis of 3710 Spanish patients included in DYSIS, a cross-sectional study carried
out with 22063 participants in Europe and Canada, on patients = 45 year-old treated with statins
for at least 3 months. Data were recorded from patient’s clinical charts. We used the ATP-III
recommendations to classify patient’s risk and define the LDL-C goal and normality or not of
the HDL-C and triglycerides concentrations.
Results: In 3710 patients (median age 65.0 year-old, 47.3% women, 69.0% with hypertension,
39.0% with diabetes mellitus), 23.8% were diagnosed with CHD (68.0% men, 27.6% women,
p<0,001); in this subpopulation 75.1% were hypertensive, 44.8% were diabetics, 16.8% were
smokers and 25.6% had a family history of premature CHD. LDL-C was not at goal in 46.9% of
patients with CHD vs. 51.4% of patients without CHD (p<0.05). The prevalence of low HDL-C
(<40 mg/dl [men], <50 mg/dl [women]) was 34.9%, higher compared to patients without CHD
(29.8%, p<0.001) and TGs were elevated in 35.1% comparing to 38.4% in patients without
CHD. Lipid profiles were abnormal in 8.2% of CHD patients.
Conclusions: In this analysis of coronary heart disease patients, despite better control of LDL-C
and TGs than the total Spanish population of the study, almost 50% of CHD patients do not
reach LDL-C target; the prevalence of low HDL-C in these patients is significantly higher and
one third show high TGs. A considerable number of CHD patients had an abnormal lipid profile;
as a result it may be of interest to explore new therapies in order to reach LDL-C goal which may
prevent cardiovascular disease with an integrated approach to other lipid risk factors as low
HDL-C and high TGs.
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Prevalence of low HDL-C in statin treated patients with cardiovascular disease. The
Dyslipidemia International Study (DYSIS-SPAIN)
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Topic: Lipids and atherosclerosis
Background and objective: Secondary prevention pretends to reduce cardiovascular (CV) events
and to achieve it; multiple risk factors should be controlled as hypertension, obesity, diabetes or
dyslipidemia. LDL-C is the usual target to treat dyslipidemia, but HDL-C has demonstrated to
be a CV risk factor especially on coronary heart disease. The aim of this post-hoc analysis was to
assess the prevalence of low HDL-C levels in statin treated patients with cardiovascular disease
(CVD) included in DYSIS study.
Methods: Analysis of 3.710 Spanish patients included in DYSIS, a cross-sectional study carried
out with 22.063 participants in Europe and Canada, on patient’s = 45 year-old treated with statins
for at least 3 months. Data were recorded from patient’s clinical charts. We used the ATP-III
recommendations to classify patient’s risk and define the LDL-C goal and normality or not of
the HDL-C and triglycerides concentrations.
Results: In 3710 Spanish patients (median age 65.0 year-old), 35.7% had established CVD
(62.1% men and 34.0% women; p<0,001), of those 76.3% were hypertensive, 45.4% diabetics,
17.6% smokers and 24.6% had family history of premature coronary heart disease (CHD). LDL-
C was not at goal in 51.1% of CVD patients vs 49.9% of non-CVD patients. The prevalence of
low HDL-C (<40 mg/dl [men], <50 mg/dl [women]) was 35.7% and it was higher than in
patients without CVD (26.4%, p<0.001) and 36.8% had elevated TG (=150 mg/dL) comparing
to 38.2% in patients without CVD. The lipid profile was abnormal on 10.4% of CVD patients and
it was significantly higher in women than men (14.3% vs 8.4%, p¼0.01)
Conclusions: At this analysis, almost 50% of patients with CVD do not achieve LDL-C goal,
despite statin treatment and a considerable amount show an abnormal lipid profile. Low HDL-C
could be an important cardiovascular risk factor as the prevalence of HDL-C is higher on
patients with cardiovascular disease. Treatment of low HDL-C added on statin therapy may
help to prevent the development of cardiovascular events.
P352
Family history of premature myocardial infarction is associated with higher blood
pressure in middle aged women
J Pitha1, M Lejskova2, P Stavek1, S Zecova3
1Institute of Clinical and Experimental Medicine, Prague, Czech Republic, 2Institute for
Postgraduate Medical Education, Prague, Czech Republic, 3Charles University Prague, 1st
Faculty of Medicine, Prague, Czech Republic
Topic: Hypertension
Background:Many candidate genes for cardiovascular diseases are now intensively investigated.
Nevertheless, family history is still one of the most important cardiovascular risk factors. We
analyzed the impact of family history of premature myocardial infarction on cardiovascular risk
factors in middle aged women.
Methods: Women aged 45-54 years representing 5% of population sample (n¼883) underwent
complete evaluation of cardiovascular risk factors. Positive family history was defined as a history
of fatal/nofatal myocardial infarction in father before age of 60 and/or in mother before age of 65
years. Differences between these two groups were analyzed by unpaired t-test or by or ? 2 test
(STATA).
Results: We found strong evidence, that women with positive family history (n¼77) were more
frequently treated for hypertension than women with negative family history (n¼806) (40 vs. 27
%; p¼0.018); had substantially higher systolic and diastolic blood pressure (123.518.0 vs.
118.518.0; p¼0.009 and 82.110.0 vs. 78.510.0 mmHg; p¼0.002); we also found weak
evidence, that they had slightly higher plasma non-HDL cholesterol (4.11.1 vs. 3.90.9 mmol/
l; p¼0.066) and apolipoprotein B (1.10.3 vs. 1.00.2 g/l; p¼0.055). No other risk factors,
including age, smoking behavior, history of diabetes, body mass index, waist circumference,
glycaemia, C-reactive protein and other plasma lipids were associated with positive family
history.
Conclusion: Family history of premature myocardial infarction was strongly associated with
hypertension and blood pressure and weakly with non-HDL cholesterol and apolipoprotein B in
middle aged women.
P353
Do particular types of left ventricular hypertrophy influence the duration and dis-
persion of QT interval in hypertensive patients?
J Kunisek1, L Zaputovic2, Z Cubranic2, L Kunisek2, V Persic1, A Ruzic1, M Zuvic
Butorac3, S Vuckovic Rapaic1
1Thalassotherapia Opatija, Opatija, Croatia, 2Clinical Hospital Center Rijeka, Rijeka, Croatia,
3University of Rijeka, Technical Faculty, Rijeka, Croatia
Topic: Hypertension
Aim: The greater excitability of concentric and eccentric LVH types is a known fact. We sought
to investigate the possible electrophysiological background (QT intervals and dispersion) of that
phenomenon particulary in relation to the asymmetric type.
Methods: During the 5.5 years, 158 patients (70 men) with essential hypertension and without
clinical evidence of ishaemic heart disease were included in the study according to prespecified
criteria. All medication was discontinued 48 hours before exercise testing and Holter monitoring.
Patients were divided into three groups with regard to LVH type: concentric (RWT>0.45 and
IVS/LVPW=1.3), eccentric (LVISd>32 and RWT<0.45), asymmetric (IVS/LVPW>1.3), and
three subgroups according to the degree of LVH: mild (IVS or LVPW 11-12 mm), moderate (IVS
or LVPW 13-14mm) and severe (IVS or LVPW =15 mm). An upper normal limit for QTc interval
was 420 ms for men and 430 ms for women; for QT dispersion it was 70 ms.
Results: The mean values of QT and QTc interval were borderline (380.647.3 ms and
425.034.4 ms, respectively), while the QT dispersion was normal (34.519.1 ms). The
QTc interval and QT dispersion were increased in severe concentric and eccentric LVH
(443 and 480 ms for QTc; 53 and 45 ms for QTd, respectively), but not significantly. QT
dispersion in men with severe LVH was significantly enlarged (67.5 vs. 30 ms, p¼0.047). The
QT interval was significantly longer in patients with complex ventricular arrhythmias (p¼0.037).
Conclusion: QTc interval and QT dispersion tend to increase proportionally to the left
ventricular mass only in the concentric and eccentric type of LVH. This could explain the
greater arrhytmogenicity of the concentric and eccentric in relation to the asymmetric LVH
type.
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Acute and long-term effects of different intensity of exercise on blood pressure of
hypertensive patients with chronic heart failure
G Caminiti, M Volterrani, A Cerrito, ME Lippi, B Sposato, A Franchini, A Arisi, G
Rosano
IRCCS San Raffaele Pisana Hospital, Rome, Italy
Topic: Hypertension
Background: To evaluate if intervaal teraining (IT) is more effective than endurance training in
improving exercise capacity blood pressure (BP) and heart rate of hypertensive subjects with
chronic heart failure (CHF)
Methods:We enrolled 36 (M/F 22/14) CHF patients (NYHA class II) median age 627 ys. They
were divided into 2 groups according to the exercise protocol. Group IT (20 patients): interval
training (exercise between 50% and 80% of VO2 peak); group ET (16 patients) endurance
training (exercise at 60% VO2 peak). The follow up period was 12 weeks. At baseline and 12
weeks patients underwent a cardiopulmonary test. A twenty-four hour ambulatory BPs was
performed after the first and the last session of the exercise protocol.
Results: After the first exercise session there were not significant betweengroups differences on
daytime and nighttime systolic BP and diastolic BP. After 12 weeks of training VO2 peak
increased in both groups in a similar manner (ITþ13; ETþ11%; p 0.18). ET group had a greater
increase of time of exercise (þ173 sec vs þ112 sec; p 0.03) than ET group. ET had a lower
reduction of rest heart rate (4 bpm vs 9 bpm) and a lower improvement of heart rate recovery al
I minute (6.2 bpm vs11.3 bpm; p0.01) After the last session IT group had a greater reduction
of daytime (16% vs 7; p 0.02) and nighttime (19% vs 8; p 0.006) diastolic blood pressure, and
lower daytime (12% vs 9; p 0.07) and nighttime (13% vs 6; p 0.002) heart rate than ET group.
Conclusions: IT seems to determine greater effects on exercise capacity and blood pressure
control in hypertensive patients with CHF.
P355
Metabolic disorders in patients with arterial hypertension (AH) and metabolic syn-
drome (MS) depending on blood pressure (BP) and intima-media thickness
O Rekovets, YM Sirenko, SY Savitskiy, EA Pavluyk, AS Vaschylko, GF Primak
National Scientific Center ‘‘M.D. Strazhesko Institute of Cardiology, MAS of Ukraine’’, Kiev,
Ukraine
Topic: Hypertension
Background: It is not clear relation ship between degrees of manifestation insulin resistance and
increased blood pressure and atherosclerosis in patients with arterial hypertension (AH) and
metabolic syndrome (MS).
Objection: to evaluate the changers of some characteristics of insulinsensitivity in patients with
AH and MS and intima-media thickness and increased blood pressure.
Methods: We studied on 124 patients (52 men and 72 women) with average age 50.31.0 years
old with mild to moderate AH and clinical signs of MS (according to ATP III), patients with
diabetes mellitus were excluded from the study. All patients were performed oral glucose
tolerance test (OGTT) with estimation of serum glucose and insulin level and calculation of
HOMA index, the total cholesterol, triglycerides (TG), HDL cholesterol determination,
calculated body mass (BMI index), measured office BP, and ABMP (Ambulatory Blood Pressure
Monitoring) estimated intima-media thickness (IMT).
Results: 36 patients (29%) had insulin resistance (IR) with HOMA>3. 88 patients (71%) had not
insulin resistance (HOMA <3). Patients with HOMA >3 had higher BMI 34,60  0,82 kg/m2
than patients without IR 32,21 0,40 kg/m2 (p<0,001). Patients who had insulin resistance had
higher BP than who did not have insulin resistance: office SBP 157,72  1,56 vs 156,16  0,91
mmHg, p<0,001, office DBP 92,06  0,60 vs 91,22 0,38 mmHg, p < 0,01. ABMP SBP 135,79
 2,12 vs 133,94  1,33 mmHg, p<0,001, DBP 81,22  1,45 vs 80,45  0,98 mmHg. Patients
with IR had higher cholesterol and TG and HDL less than patients without IR: cholesterol 6,79
 0,15 vs 6,23  0,12 mmol/l, p<0,01, TG 2,12  0,20 vs 1,71  0,60 mmol/l, p<0,01, HDL
level 1,13  0,03 vs 1,19  0,02 mmol/l, p<0,01. Patients with IR hah more aggressive
atherosclerosis compared without IR patients. Patients with HOMA > 3 had IMT 1,52 
0,01 vs 1,27 mm, p<0,01, who had HOMA < 3.
Conclusions: Patients with AH and insulin resistance had higher body mass index, office blood
pressure and BP during ABMP, level of cholesterol, triglycerides, intima-media thickness (IMT)
and less HDL cholesterol compared patients without insulin resistance.
P356
Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure
management in pregnancy
A Ascione1, F Stoppoloni1, G Vernetti1, A Sciarappa1, M Borgia2
1Buon Consiglio Fatebenefratelli Hospital, Naples, Italy, 2Vincenzo Monaldi Hospital, Naples,
Italy
Topic: Hypertension
Objective: To investigate plasma brain natriuretic peptide (BNP) concentrations in association
with blood pressure (BP) in pregnant women at baseline and after antihypertensive drug
treatment.
Patients and methods: We prospectively examined 86 women with newly diagnosed essential
hypertension without target organ damage by blood pressure holter monitoring, whose mean age
was 27.7 þ/ 10.9 years. They were before three months gone with child. Mean blood systolic/
diastolic pressure in 24 hours was 146,5/98,8 mmhg.Treatment initiation began with metildopa
250 mg/bis in day and was doubled at 4 weeks in cases of inadequate BP control. If indicated, at
8-week-follow-up metildopa 500 mg/bis in die alone or with nyphedipine 30 mg was added.
BNP levels were measured at baseline and after 2 months of antihypertensive treatment.
Results: At baseline plasma BNP levels were found to be related to systolic BP (r ¼ 0.27,
P<0.001), independent of age, weight, smoking status, and left ventricular mass index estimated
by echocardiography (P ¼ 0.002). Additionally, higher BNP concentrations were observed in
patients with stage 2 hypertension compared with those with stage 1 (median 34.9 vs. 25.9 pg/ml,
P ¼ 0.022). Multivariate analysis showed a positive association between BNP and systolic BP
variability (P ¼ 0.034). At follow-up, 60.1% of the participants who had achieved BP control
showed decreased BNP levels in contrast to those with poor BP control (median change 14.5
vs. 1.3 and median range from 34.4 to 4.4 vs. 9.6 to 10.9, respectively, P<0.001).
Conclusion: In this hypertensive population of pregnant, increased BNP concentrations are
associated with higher BP levels and systolic BP variability. The fall of BNP observed in those
who achieved BP control indicates that BNP could be used as a biochemical marker of effective
BP control and target organ protection
P357
Correlations between the metabolic syndrome and other cardiovascular risk factors
on the outcome of hypertensive patients
E Belu1, R Musetescu1, A E Musetescu2, V Belu3, D -D Ionescu1, V Mechirova4
1Cardiology Center, Craiova, Romania, 2University of Medicine and Pharmacy of Craiova,
Craiova, Romania, 3Cardiology Depart., Campulung, Romania, 4University of Medicine, Kosice,
Slovak Republic
Topic: Hypertension
Purpose: The metabolic syndrome (MS) includes several interrelated cardiovascular risk factors
that have been shown to increase the risk of heart disease. Taking into account the numerous
cases of patients suffering from hypertension and metabolic syndrome (MS) in this area and the
short data regarding the profile of the romanian hypertensive patient, we have propounded to
assess the risk profile for these patients.
Method: We have included in the study group patients admitted in Craiova Cardiology Center
in 2007 from the County registry of hypertension and we have divided them in 2 subgroups :
individuals with hypertension and metabolic syndrome according to NCEP criteria and the
second subgroup of hypertensives without metabolic syndrome. The follow-up period lasted for
two years. We performed multivariate logistic regression analyses in order to assess the
relationships between hypertension, metabolic syndrome, target organ disease, dyslipidemia,
visceral obesity and diabetes mellitus.
Results: We have evaluated 542 patients with metabolic syndrome and hypertension mean age
of 55,12 years. There were 48,72% men and 51,28 % women. The risk of end stage renal disease
was estimated at 2,56%. The profile of our MS patients was depicted by older age, higher systolic
pressure, higher body mass indexes The procent of patients with diabetes mellitus was 34,19%,
but 27,35% from them had impaired fasting glucose.This population had more left ventricular
hypertrophy, renal and cardiac diseases were more prevalent (p<0.01), and they received more
antihypertensive drugs (p<0.05). There were only 17,09% from our patients who achieved the
target values of blood pressure.
Conclusions: The study shows the poor adherence to treatment of hypertensive patients with
metabolic syndrome. These patients are achieving the target values for blood pressure in a very
small percent. The number of important cardiovascular events is increased in the case of these
young patients with a very high risk profile.
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Trends in threshold SBP and its impact on mortality in the hypertensive patients in 25
years of follow-up
UO Andersen, GB Jensen
Copenhagen City Heart Study, Copenhagen, Denmark
Topic: Hypertension
Aims: To evaluate trends in threshold SBP (the SBP-value before start of antihypertensive
therapy) and to evaluate the impact of threshold SBP on mortality.
Design and methods: Copenhagen City Heart Study is a prospective longitudinal epidemio-
logical study. The study population consists of subjects that in the next survey start anti-
hypertensive therapy. The subjects were followed over 25 years with 1 to 4 measurements on
each subject. The BP measurement was fully standardised and measurement method was
unchanged throughout the observation period. A questionnaire concerning risk factors and
medical therapy exercise was completed by the participants and double-checked by the
technicians. Data were analysed by random effect model for trends and by Cox analysis.
Results: Threshold SBP did not change during 25 years of follow-up. Men, obese and elderly
started antihypertensive therapy at a higher threshold value than their counterparts. Mortality
increased by increasing threshold value.
Conclusion: Hypertensive patients that start treatment on low SBP-values survive better that
the patients that start antihypertensive treatment on high SBP values. In the past 25 years
threshold SBP has not decreased. It is essential to start antihypertensive therapy earlier if we
want to improve life expectancy in the hypertensive population.
P359
The relationship between the sleep quality and blood pressure values before and
after therapy with rilmenidine
S Farsky, R Sidlo
Slovak League against Hypertension, Martin, Slovak Republic
Topic: Hypertension
The study was aimed at determining a potential correlation between the morning values of
blood pressure and the sleep quality during the previous night in patients with fixed hyperten-
sion treated with medicaments, and at finding whether a therapy with rilmenidine has positive
effects not only on the value of blood pressure, but also improves the sleep quality through
decrease in the sympathicus activity.
We have examined 993 patients with essential hypertension, that have not reached the target
values of blood pressure in spite of a therapy with medicaments, and the abdominal obesity was
found in 79% of the patients. The therapy with rilmenidine was added to their previous
treatment, and the study duration was 3 months. At the beginning and at the end of the study,
there were performed anthropometric and basic biochemistry examinations, a repeated
measurement of the blood pressure and heart rate in 10 min intervals in outpatient departments
of general practitioners, as well as an evaluation of the sleep quality according to the Athens
Insomnia Scale questionnaire.
After adding rilmenidine to their hypertension therapy, there was found a decrease in systolic
pressure, diastolic pressure, heart rate and sleep quality. The decrease was highly significant
(p<0.0001). The coefficients of correlation between the systolic blood pressure values and the
sleep quality were 0.08 (p<0.0226) at the beginning of the study and 0.14 (p< 0.0001) at the end
of the study, and were 0.08 (p<0.015) between the diastolic blood pressure values and the sleep
quality at the end of the study. The coefficients of correlation between a difference of the
systolic blood pressure values and a difference between results of the questionnaire at the
beginning and the end of the study were 0.09 (p< 0.0064).
Results of our study acknowledged a positive effect of rilmenidine in hypertension therapy due
to a significant decrease of the blood pressure, slowing the heart rate and improvement of the
sleep quality evaluated by the standardized questionnaire. In addition, interesting associations
were found between the sleep quality and values of the systolic blood pressure, and partly also
diastolic blood pressure before the start of therapy with rilmenidine and during the therapy.
These results are in concordance with the actual literature data that demonstrated that a
decreased length and an impaired quality of sleep have a negative effect on blood pressure
values and occurrence of hypertension as well as the overall cardiovascular risk in adolescent and
adults persons.
P360
High prevalence of prehypertension and hypertension among young andmiddle-aged
bank employees in Hungary
S Steiner1, E Helis1, JG Fodor1, P Turton1, S Sonkodi2, B Sonkodi2
1University of Ottawa Heart Institute, Ottawa, Canada, 2SZTE, AOK, I. Belgyo´gya´szati
Klinika, Szeged, Hungary
Topic: Hypertension
Purpose: Hungary has one of the highest mortality rates due to strokes among the European
Union countries. As elevated blood pressure (BP) is the principal risk factor for strokes, we
assessed BP levels in a sample of working population in Budapest, Hungary.
Methods: 1000 bank employees (mean ageSD ¼32.58.1) were screened for their BP and
other CV risk factors at their worksite. The respondents included 304males (mean ageSD
¼30.96.4) and 696 females (mean ageSD ¼33.28.9). Respondents were classified as
normotensives, prehypertensives (PHTN) and hypertensives (HTN) according to their BP
levels. The BP and heart rate (HR) were measured using an automated instrument.Body height,
body weight and waist circumference (WC) were measured and BMI was calculated. Self-
reported information regarding smoking was recorded. Group comparisons were made by
ANOVA followed by Tukey s post hoc test.
Results: 46% of respondents were identified as PHTN (systolic blood pressure (SBP) between
120-139 mmHg or diastolic blood pressure (DBP) between 80-89 mmHg) and 17.3% as HTN
(SBP = 140 mmHg and/or DBP = 90 mmHg and/or on hypertensive medications). A progressive
and significant increase in HR, WC and BMI was ascertained as BP levels increased (see Table).
Interestingly, no age difference was found between normotensives and PHTN, while HTN
individuals were significantly older. Almost a third (29%) of all respondents were smokers.
Conclusions: The high prevalence of elevated BP and smoking might provide a partial
explanation for the excessive stroke mortalityand unfavourable cardiovascular profileof Hungary
as compared with other European countries.
Participant characteristics
Blood Pressure Class Normotension Prehypertension Hypertension
N (%) 368 (36.8%) 459 (45.9%) 173 (17.3%)
Age, years 31.77.7 31.77.4 36.39.7 #
Waist Circumference, cm 75.6  9.8 78.811.3 86.414.1#
BMI, kg/m2 22.3  3.2 23.13.3 25.14.5#
SBP, mmHg 108.5  7.9 124.76.4 13915.5#
DBP, mmHg 70.1  6.4 806.4 92.59.6#
Heart Rate, bpm 73.5  10.1 78.311.3 84.413.4#
All data are shown as mean SD. P < 0.0001 for comparison against normotensives.# P <
0.0001 for comparison of PHTN vs. HTN.
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The influence of depression disorders on the blood pressure in adolescents
V Romero, J Villasmil, E Silva, G Bermudez
Instituto de Enfermedades Cardiovasculares, Maracaibo, Venezuela
Topic: Psychosocial factors and stress
Objective: To determine the effects of depression on the blood pressure (BP) in adolescents.
Methods: This study was carried out in a random sample of schools from Maracaibo, Venezuela.
The participants were 560 adolescents, males (n¼ 310) and females (n¼ 250), age-mean¼ 14.19
years (SD¼1.52), who were systolic and diastolic BP recorded in two schools day, in sitting
position and using oscillometric method (Dinamap). The adolescents completed the Zung self-
rating depression scale to assess depression symptoms, and they were classified according the
result of this scale in 3 categories: Normal (N), Minimum Depression (MiD) and Moderate
Depression (MoD). Statistics Methods: The data are presented as mean  standard deviation.
The One-way ANOVA was used to study the effects of the different depression categories on
the BP levels, and the Tukey test was applied for the mean comparisons.
Results: The prevalence of MoD was 8.2% (n¼46) and it was 28.2% (n¼158) for MiD in all
subjects. The systolic/diastolic BP values were: 103.110.3/57.65.6 mmHg in adolescents with
MoD, 106.812.2/60.76.9 mmHg in subjects with MiD and 108.612.2/60.56.7 mmHg in N
adolescents. The ANOVA showed statistically significant effects of the depression disorders on
both systolic BP (F ¼ 4.816) and diastolic BP (F ¼ 4.384). The analysis post hoc evidenced
systolic and diastolic BP values statistically lower in adolescents with MoD than those with MiD
(p<0.01) or N (p<0.01).
Conclusions: The present results provide evidence for an association between depression
disorders and low BP in the adolescent population. This study do not evaluated the mechanism
behind the findings; however, it is possible that there is a relationship between symptoms of
depression and some indications of abnormal autonomic nervous function; this abnormality
would explain the low BP. More investigations are needed to explore these associations in
adolescents.
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Correlates of nondipping blood pressure pattern among middle-aged men and
women
EClays1, DDe Bacquer1, KVanHerck1,MDe Buyzere2, MKornitzer3, F Kittel3, GDe
Backer1
1Ghent University, Ghent, Belgium, 2Ghent University Hospital, Ghent, Belgium, 3Free University
of Brussels (ULB), Brussels, Belgium
Topic: Cardiovascular epidemiology
Purpose: There is a growing body of evidence suggesting that nondipping (i.e. a lack of
nocturnal blood pressure (BP) fall) has prognostic value for cardiovascular disease (CVD).
Knowledge of the underlying mechanisms and associative factors is still incomplete. Some socio-
demographic and behavioral factors have been shown to correlate with nondipping, while very
little is known about psychosocial correlates. The aim of this study was to examine correlates of
nondipping in a sample of healthy middle-aged workers.
Methods: Results are based on observations in 170 day-time workers (60% male, mean age 51
years) from the Belstress II study with no history of CVD. Socio-demographic (gender, age,
educational level), behavioral (smoking status, alcohol consumption, physical activity, sleep
pattern) and psychosocial factors (job stress according to the Demand-Control model, and
symptoms of depression, anxiety and vital exhaustion based on the CES-D scale) were assessed
by means of questionnaires. Height and body weight were measured during standardized bio-
clinical examinations. On a regular working day, participants wore an ambulatory BP monitor
(Spacelabs Medical) during 24 hours. Nondipping was defined as a decline from wake to sleep
BP of less than 10%. Associations were studied bymultiple logistic regression analysis.
Results: Nondipping in systolic blood pressure (SBP) was present in 22% and nondipping in
diastolic blood pressure (DBP) in 9% of the study sample. The prevalence of nondipping was
higher in females, lower educated and obese persons. After adjusting for gender, educational
level and body mass index, the risk for nondipping in SBP was (borderline) significantly
increased by high symptoms of depression (OR ¼ 2.25; 95% CI ¼ 0.97-5.23), anxiety (OR
¼ 3.32; 95% CI ¼ 1.43-7.72) and vital exhaustion (OR ¼ 2.24; 95% CI ¼ 0.89-5.60), while
nondipping in DBP was (borderline) significantly related to sleep problems (OR¼ 2.68; 95% CI
¼ 0.85-8.40), job strain (defined as the ratio of demands over control) (OR per 1 SD in job strain
¼ 1.74; 95% CI¼ 1.10-2.77), high symptoms of depression (OR¼ 2.83; 95% CI¼ 0.90-8.94) and
vital exhaustion (OR ¼ 2.99; 95% CI ¼ 0.90-9.96). No associations were found with age,
smoking, alcohol consumption and physical activity.
Conclusions:This study found that nondipping was associated with female gender, lower
educational level, obesity, sleep problems, job strain, and symptoms of depression, anxiety
and vital exhaustion in a sample of middle-aged workers.The role of psychosocial factors should
be considered when examining nondipping.
P364
Factors associated with prediabetes in adult children of patients with premature
coronary heart disease; the study of families of patients with premature coronary
heart disease
MV Konnov, LM Dobordzhginidze, AD Deev, NA Gratsiansky
Institute of Physico-Chemical Medicine, Moscow, Russian Federation
Topic: Diabetes
Objective: To elucidate associations of impaired fasting glucose (IFG) and/or impaired glucose
tolerance (IGT) in adult children of patients with premature coronary heart disease (CHD) and/
or elevated low density lipoprotein cholesterol (LDL-C) with some their own characteristics and
those of their parents.
Methods: We examined members of 210 families of patients with premature CHD (91.4%) and/
or with LDL-C =3.36 mmol/l including 136 consorts of patients-probands, and 251 children aged
16-37 years. Children had neitherovert vascular disease nor diabetes mellitus (DM). Charac-
teristics analyzed included tobacco smoking, alcohol consumption, oral contraceptives use,
height, body mass index, waist circumference, heart rate (HR), systolic/diastolic BP, total and
high density lipoprotein cholesterol, LDL-C, triglycerides, serum basal glucose, IFG, IGT, DM
(ADA criteria) and (in parents) education level and menses. High BP was defined as pre-
hypertension or hypertension (NHBPEP-4 or JNC-7 depending on age). IFG and IGT of
children were combined and designated prediabetes (preDM). Associations were assessed by
logistical regression analysis with age, sex adjustment.
Results: PreDM was found in 35 of 251 children (13.9%). DM of neither parent-proband nor of
any parent was related to preDM in children. Factors related to the presence of preDM with
p<0.1 in univariate analysis (children s high BP, HR, triglycerides, waist circumference, alcohol
consumption of proband, and basal glucose, diastolic BP, metabolic syndrome, height and waist
circumference of non-proband) were included into stepwise regression procedure. Character-
istics independently linked with preDM turned out to be own high BP; basal glucose of non-
proband; and own HR (table).
Conclusion: In this group of grown-up children of patients with premature CHD: 1) preDM was
not related to DM of their parents; 2) preDM was not related to any studied characteristic of
parent with premature CHD; 2) basal glucose of parent - nonproband, and own high BP and HR
were independently associated with preDM.
Results of multifactorial analysis
Independent predictors of
preDM in adult children
OR 95%CI p
Own high BP 2.954 1.706 - 5.115 0.0001
Top tertile of basal glucose of
non-proband (=5.37 mmol/l)
vs 2 bottom tertiles (<5.37 mmol/l)
5.183 1.722 - 15.60 0.003
Top tertile of own HR (=75 beats
per minute) vs bottom tertile
(=66 beats per minute)
3.361 1.253 - 9.018 0.016
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Risk factors for cardiac autonomic neuropathy in diabetes and the significance of a
multifactorial intervention for its prevention
C Voulgari1, M Psallas1, A Kokkinos1, V Argiana1, I Moyssakis2, D Perrea3, N
Katsilambros1, N Tentolouris1
1First Department of Propaedeutic Medicine, Athens University Medical School, Laiko General
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3Laboratory for Experimental Surgery and Surgical Research, Athens University Medical School,
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Topic: Diabetes
Purpose: Cardiac autonomic neuropathy (CAN) is a common diabetes complication and confers
an increased cardiovascular risk. Literature data on the association between CAN with clinical
and metabolic correlates in diabetic subjects are limited, especially in type 2 diabetes. We aimed
to examine the relationship between CAN with clinical and metabolic parameters, and other
diabetes complications.
Methods: We consecutively recruited 1000 diabetic subjects (type 1 diabetes¼400; type 2
diabetes¼600). Participants with overt nephropathy, and macrovascular complications were
excluded. CAN was diagnosed when two out of the four classical autonomic function tests were
abnormal.
Results: In type 1 diabetes, multivariate logistic regression analysis, after adjustment for gender,
age, central fat distribution, diabetes duration and lipids demonstrated that the odds (OR, 95%
confidence intervals) of CAN increased with factors such as pubertal diabetes onset [1.08 (1.03-
1.24), P<0.001], higher central fat distribution [1.36 (1.01-2.02, P¼0.03], higher blood pressure
[1.16 (1.03-1.05), P¼0.01], HbA1c [1.69 (1.07-2.76), P¼0.02] and fasting glucose levels [1.01
(1.00-1.01), P<0.001], higher LDL-cholesterol [1.01 (1.00-1.02), P¼0.03] and triglycerides
levels [1.58 (1.24-1.48), P¼0.03], microalbuminuria [1.24 (1.12-1.36), P¼0.02], retinopathy
[1.13 (1.04-1.41), P¼0.01] and smoking [1.10 (1.02-1.40), P¼0.02]. The same analysis in patients
with type 2 diabetes, after adjustment for gender, age, blood pressure, lipids, and antidiabetic
treatment demonstrated that central fat distribution [1.08 (1.00-1.39), P¼0.02], longer diabetes
duration [1.20 (1.09-1.34), P¼0.006], higher HbA1c [1.19 (1.02-1.38), P¼0.02], fasting glucose
[1.21 (1.12-1.31, P¼0.002)], LDL-cholesterol [1.35 (1.04-1.75), P¼0.02], triglycerides levels
[1.30 (1.00-1.68), P¼0.03], microalbuminuria [1.20 (1.14-1.36), P<0.001], retinopathy [1.24
(1.16-1.35), P¼0.008], smoking [1.22 (1.14-1.49), P<0.001] and smoking severity (>20
cigarettes/day) [1.32 (1.26-1.64), P<0.001] were independently associated with higher odds
of CAN.
Conclusions: In type 1 diabetes, the risk of CAN is associated with pubertal diabetes onset,
worse glycaemic control, higher blood pressure levels, and dyslipidaemia, presence of micro-
vascular complications and smoking. In patients with type 2 diabetes the risk of CAN increased
with central fat distribution, longer diabetes duration, worse glycaemic control, dyslipidaemia,
retinopathy and/or microalbuminuria, smoking and smoking severity. Our findings emphasize
the need for a multifactorial intervention for the prevention of CAN in diabetes.
P366
Absence of gender influence on the prognosis of diabetic patients in an outpatient
setting, the Barbanza Diabetes Study
R C Rafael CarlosVidal Perez, F Otero-Ravina, E Rodriguez Moldes, C De Frutos, L
Vaamonde, L Grigorian Shamagian, P Mazon Ramos, JR Gonzalez-Juanatey
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The Barbanza Diabetes Study group
Purpose: Previous data have shown that in the patients of male sex, the diabetes mellitus has a
lesser impact over the cardiovascular prognosis. The aim of our study was to assess the influence
of the gender and prior cardiovascular disease on the prognosis of diabetic patients in an
outpatient setting.
Methods: Multicenter prospective cohort study involved 1423 consecutive patients with
diabetes mellitus who were recruited by 31 primary care physicians. The patients characteristics
were recorded and they were followed up for 4510 months.
Results: We studied patients (50% male) with mean age 66 years old. Women were significantly
older (67 vs. 64 years, p<0.001) and with more risk factors (64 vs. 53% with more than one,
p<0.01) compared with men. Women had less prior cardiovascular disease (24 vs. 29%, p<0.05)
or microalbuminuria (32 vs 44%, p<0.001) in this cohort. There were also differences in
treatment, women had more renin-angiotensin blockade drugs (60% vs. 50%, p<0.01) and
insulin prescribed (20 vs. 11%, p<0.001). At the end of follow up there were no significant
differences on cardiovascular mortality (women 2.4% and men 3.7%, p¼0.354) or cardiovascular
hospital admissions (12.5% vs. 14.8%, p¼0.351). On the other hand a greater cardiovascular
mortality in patients with prior cardiovascular disease was found (6.1 vs 2.1%, p<0.05), but in this
group there were not gender related differences. We adjusted by age, risk factors and treatment
this last finding and we didn’t find differences between both sexes in the cardiovascular event
rate (death, admissions) with a hazard ratio 0.64 (95% confidence interval 0.38-1.08), and neither
differences in patients without prior cardiovascular disease were found. The age and micro-
albuminuria were, in both sexes, the only significant prognosis factors for outcome.
Conclusion: The cardiovascular impact of diabetes is the same in men and women in our
outpatient setting; this finding could justify the absence of gender differences in the strategies of
cardiovascular prevention in diabetic patients.
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Increased ventricular arrhythmogeneity in subjects with type 2 diabetes and cardiac
autonomic neuropathy: assessment of the ventricular gradient
C Voulgari1, I Moyssakis2, P Dilaveris3, D Perrea4, D Papadogiannis1, C Stefanadis3, N
Tentolouris1
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Athens, Greece, 4Laboratory for Experimental Surgery and Surgical Research, Athens University
Medical School, Athens, Greece
Topic: Diabetes
Purpose: Cardiac autonomic neuropathy (CAN) is a common diabetes complication associated
with dispersion of ventricular repolarization and arrhythmia provocation. QT-prolongation has
often been criticized as a poor indicator of ventricular arrhythmogeneity. The spatial QRS-T
angle (spQRS-Ta) is a novel vectorcardiographic marker, akin to the concept of the ventricular
gradient, a robust index of ventricular electrophysiological heterogeneity and a dominant
predictor of cardiovascular morbidity and mortality. We examined differences in the spQRS-
Ta in subjects with type 2 diabetes (T2DM) with and without CAN.
Methods: A total of 232 subjects with T2DM (105 with CAN and 127 without CAN) (age
58.49.1 years) and 232 matched (by age and sex) controls were studied. Diagnosis of CAN was
based on the classical autonomic function tests. All subjects underwent a digital 15-min ECG
and 30-min heart rate recordings. ECG parameters were measured using the MEANS program.
Indices of the heart rate variability (HRV) were obtained using the VariaCardio system. Ankle-
brachial-pressure index (ABI), LV mass index (LVMi) and myocardial performance index (Tei-
index) were assessed by ultrasonography.
Results: The spQRS-Ta was higher in the subjects with T2DM in comparison with the controls
(24.510.7¯ vs. 9.74.5¯, P<0.001) and in the subjects with CAN than in those without CAN
(30.111.3¯ vs. 19.57.1¯, P<0.001). No differences were found in the QT-interval between the
studied groups. Multivariate linear regression analysis in the subjects with T2DM demonstrated
independent associations between the spQRS-Ta, the presence and the severity of CAN
(P<0.001), HbA1c (P<0.001), duration of diabetes (P¼0.004), HOMA-IR (P<0.001), diabetic
cardiomyopathy (P¼0.02) and sympatho-vagal imbalance (P<0.001).
Conclusions: The spQRS-Ta is increased in patients with T2DM and CAN, suggesting
ventricular repolarization heterogeneity. The metabolic and cardiovascular factors associated
with the presence of CAN in diabetes (duration and degree of hyperglycaemia, diabetic
treatment) were also independently associated with ventricular arrhythmogeneity, assessed
by spQRS-Ta. SpQRS-Ta was also independently associated with the structural and functional
substrate involved in diabetic cardiomyopathy. QT and its parameters were found to be
impaired by CAN. SpQRS-Ta is an effective, noninvasive, low-cost test for the early detection
of CAN and prospective studies will further show if its determination can help clinicians better
stratify diabetic individuals and prevent CAN s clinical manifestations and symptoms that may
cause lethal outcomes.
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Atorvastatin worsens glucose metabolism and insulin sensitivity in patients with
metabolic syndrome/type 2 diabetes
K Koh1, M Quon2
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Background: We compared the effects of atorvastatin on glucose metabolism and insulin
sensitivity in hypercholesterolemic patients with and without metabolic syndrome/diabetes.
Methods:Randomized, single-blind, placebo-controlled, parallel study. Age, sex, and body mass
index were matched. Forty-four patients were given on placebo and 42, 44, 43, and 40 patients
were given daily on atorvastatin 10, 20, 40, and 80 mg, respectively during a 2 month treatment
period. Nineteen patients on placebo and 18, 18, 20, and 18 patients on atorvastatin 10, 20, 40,
and 80 mg were metabolic syndrome/diabetes.
Results: Atorvastatin 10, 20, 40, and 80 mg significantly reduced LDL cholesterol (median %
changes; 39, 47, 52, and 54%) and apolipoprotein B levels (31, 37, 44, and 48%) after 2 months
therapy when compared with baseline (all P<0.001 by paired t-test) or when compared with
placebo (P<0.001 by ANOVA). Atorvastatin 10, 20, 40, and 80 mg significantly increased insulin
(27, 63, 36, and 58%) and glycated hemoglobin levels (4, 7, 7, and 8%) from baseline (all P<0.05
by paired t-test) or when compared with placebo (P¼0.011 for insulin and P¼0.004 for glycated
hemoglobin by ANOVA). Atorvastatin 10, 20, 40, and 80 mg decreased plasma adiponectin levels
(0, 18, 2, and 11%) and decreased insulin sensitivity (2, 6, 4, and 6%) when compared with
baseline (P¼0.732, P¼0.024, P¼0.508, and P¼0.128 for adiponectin; P¼0.233, P¼0.012,
P¼0.008, and P¼0.003 for insulin sensitivity by paired t-test) or when compared with placebo
(P¼0.147 for adiponectin and P¼0.006 for insulin sensitivity by ANOVA). However, the
magnitude of these percent changes (glycated hemoglobin, insulin, adiponectin, and QUICKI)
were not significantly different among the four different doses of atorvastatin despite dose-
dependent changes in apolipoprotein B reduction. These effects were not significantly different
between patients with and without metabolic syndrome/diabetes.
Conclusions: Atorvastatin significantly increased insulin and glycated hemoglobin levels and
reduced insulin sensitivity in hypercholesterolemic patients with metabolic syndrome/diabetes
independent of dosage and the extent of apolipoprotein B reduction.
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Type 2 Diabetes Mellitus: a true coronary artery disease risk equivalent?
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Purpose: Several studies have suggested the risk of mortality is equivalent for non-diabetic
patients with known coronary artery disease (CAD) or previous myocardial infarction (MI) and
for diabetic patients without previous known CAD or MI. This study aims to investigate the
prognostic power of diabetes mellitus (DM) and CAD in predicting cardiovascular (CV) risk
following a MI.
Methods: 178 consecutive patients (70.511.7 years old, 64% males) with DM or known CAD
admitted with a MI. Data collected: admission glycemia, creatinine, haemoglobin [Hb] and C
Reactive Protein (PCR); maximum troponin levels (MaxTrop); glomerular filtration rate (GFR)
by MDRD formula; maximum Killip Class (mKC); CAD extension; GRACE risk score (GS).
Patients were followed for 24 months. Patients were divided in 2 groups (Group A: diabetics
without known CAD; Group B: non-diabetics with previous known CAD).
Results: Patients of Group A had significantly higher: intra-hospital mortality (17.7% vs 6.2%,
p¼0.03, OR 3.33), GS (173.9 vs 157.2, p¼0.027), risk for acute heart failure (50.4% vs 33.9%,
p¼0.032, OR 1.99); average mKC (1.92 vs 1.60, p<0.001), PCR (4.52 vs 1.37, p¼0.004) and, as
expected, admission glycaemia (12.62 vs 7.21). Patients in both groups did not differ in
admission Hb, MaxTrop (despite a trend for higher MaxTrop in group A; 52.3 vs 40.9,
p¼0.2), creatinine, GFR and, surprisingly, CAD extension (the number of arteries and segments
with significant stenotic lesions was not significantly different in both groups). Cardiovascular
risk during follow-up was similar in patients from both groups, as evidenced by a similar
mortality rate, risk for recurrent angina, reinfarction, stroke and decompensated heart failure.
Conclusions: Diabetic patients without previous known CAD had a higher mortality rate and a
higher risk for acute heart failure. However, DM was truly a CAD risk equivalent in what
concerns myocardial necrosis extension and CAD severity as analyzed by coronariography. Also,
CV risk during a 2 year follow-up was not significantly different in both groups, attesting the
equivalence between DM and known CAD. This highlights the importance of aggressive
therapeutic approach for all diabetic patients with a MI.
P370
Difference of positive remodeling area between DM and non-DM heart disease
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Topic: Diabetes
Background and Purpose: Compensatory enlargement of coronary artery is frequently inves-
tigated in patients with angiographically normal coronary arteries by intracoronary ultrasound
examinations (IVUS). Although diabetes mellitus (DM) is well known to be one of the coronary
risk factors, little is known whether it also affects on positive remodeling or not. We investigated
the effect of diabetes mellitus on development of positive remodeling.
Method: We investigated consecutive 112 ischemic heart disease patients who had been
performed percutaneous coronary interventions (PCI) to mid-LAD (left anterior descending)
lesions using IVUS procedure from May 2008 to June 2009 in our hospital. We measured
external elastic membrane (EEM) diameter and minimum lumen diameter at the proximal site
of LAD, with no significant stenosis. The positive remodeling ratio was determined as follows;
EEM diameter100/minimum lumen diameter. Patients were assigned into DM or non-DM
groups (PG 193.5mg/dl v.s. 124.5mg/dl, respectively).
Results: There was no significant difference in minimum lumen diameter between DM and
non-DM groups (3.29þ/0.70v.s.3.50þ/0.75mm, respectively). However, positive remodeling
ratio was significantly (p<0.05) grater in DM group (149þ/26%) than in non-DM group (138þ/
24%).
Conclusion: It is revealed that the positive remodeling is more advanced in diabetic patients
although coronary artery seems to be normal angiographically.
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Natriuretic peptides in at risk cohorts: considerations for clinical interpretation
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Topic: Biomarkers
The STOP HF Investigators
Background: B-type natriuretic peptide(BNP) has been proffered as a screening tool for
echocardiography referral and detection of LVSD. However, despite its excellent sensitivity
there are concerns surrounding its poor specificity and the significant issue of false positives .
The literature has repeatedly established associates of higher BNP, however, there is a dearth of
information on the magnitude of impact of these associates and whether these factors confound
BNP expression.
Objective: To identify the principal associates of BNP and examine the extent of association
within a population with cardiovascular risk-factors taking cardio-active therapies.
Methodology: We explored the baseline data set of the ongoing Screening to Prevent Heart
Failure Study, a prospective study of primary care based individuals with cardiovascular risk-
factors and no documented ventricular dysfunction. Univariate and multivariate(logistic
regression) models determined associates of BNP. Using sub-set analyses, the foremost
associates of BNP were established and the extent to which they were associated with BNP
was examined.
Results: Complete data was available in 1122 individuals (mean age 65, 47%Male, 66%Hyper-
tension, 49%Hypercholesterolemia, 25%Obesity, 16%Coronary artery disease49% of whom
had myocardial-infarction(MI), 15%Smoking; 11%Diabetes). The most common medications
were Statins(63%), Anti-platelet(49%), Beta-blockers(30%), ACE-Inhibitors(28%), AIIA(26%),
Thiazides(20%), Calcium-Antagonists(16%) and Anti-diabetics(11%). Median biomarker levels
fell within normal ranges. Multivariate associates of BNP were age, female, systolic and diastolic
blood-pressure, heart-rate, beta-blockers, arrhythmia(all p<.001), calcium-antagonist and MI(all
p<0.5).
BNP was examined in the context of age, plotting it against age for each individual. A linear
regression line was fitted through Log(BNP) for both gender. Using the age-framework,
potential associates of BNP were assessed by plotting the median-BNP by sliding decade of
age for those with and without a particular risk-factor(looking for a prominent departure between
the lines that persisted with age). In particular, beta-blockers were associated with a 1.7-fold
increase in BNP.
Conclusions: In defining cut-offs for BNP screening, at minimum, certain characteristics, co-
morbidities and therapies must be accounted for. In addition to age-referencing, not accounting
for beta-blockers in particular, may in part explain the low specificity associated with BNP
screening to date. In research efforts, caution should be taken in using BNP as an end-point in
populations on beta-blockers.
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Can glucose metabolism markers predict post-prandial glycaemia in non-diabetic
acute coronary syndrome patients?
S Monteiro, C Lourenco, R Teixeira, E Jorge, R Batista, P Lazaro, P Monteiro, L
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Introduction: Glucose metabolism abnormalities are important prognostic predictors in acute
coronary syndrome (ACS) patients. Several recent studies have suggested the importance of
several glucose metabolism markers and the performance of an oral glucose tolerance test
(OGTT) in all non-diabetic ACS patients. However, a question persists: is there a correlation
between these markers and post-prandial glycaemia, as assessed by the OGTT?
Aim: To evaluate, in a population of patients not known to be diabetic, admitted for ACS and
submitted to OGTT during hospital stay, if there is a relationship between admission glycaemia
(AG), glycaemia variation (GV) and glycaemia normalization (GN) and the post-prandial
glycaemia determined in the OGTT.
Population and methods: Retrospective analysis of 259 patients not known to be diabetic,
admitted for ACS in a single centre and submitted to OGTT during their hospital stay. GV was
defined as the difference between AG and the lowest glycaemia value during hospital stay; GN
was defined as the difference between AG and the first fasting glycaemia.
Results: After OGTT performance, only 79 patients (30.5%) had a normal glucose metabolism,
while 92 (35.5%) showed impaired fasting glucose or impaired glucose tolerance and 88 (34.0%)
where diagnosed as diabetics. Patients with an higher post-prandial glycaemia in the OGTT
were older, less frequently in Killip class I on admission, had more often high blood pressure,
dyslipidaemia, an abnormal ECG and higher heart rate at admission, a diagnosis of myocardial
infarction and lower glomerular filtration rate. The spearman correlation test showed that both
AG, GV and GN had a positive correlation with higher post-prandial glycaemia values, with the
correlation being best for AG (coefficient 0.468; p<0.001) and worst for GN (coefficient 0.281;
p<0.001). Multivariate analysis confirmed that all three markers were independent predictors of
the post-prandial glycaemia in the OGTT.
Conclusions: In ACS patients without a previous history of diabetes, there is a good correlation
between markers of glucose metabolism impairment and post-prandial values of glycaemia
determined by OGTT. This fact, never before described, may improve our knowledge of
metabolic abnormalities in ACS patients, thus contributing to their better clinical management.
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Usefulness of natriuretic peptides in primary health care, an explorative study in
elderly patients
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Topic: Biomarkers
Background: High levels of negative predictive value (NPV) has been shown (95-100%) for
younger patients.
Aim: Primarily to explore the (NPV), positive predictive value (PPV), sensitivity and specificity
of natriuretic peptides. Secondarily, to evaluate the impact of gender and age in elderly patients
with systolic heart failure (HF).
Methods: This is an explorative study from one primary health care centre where 109 patients
with symptoms of HF were referred for an echocardiographic examination followed by a
cardiovascular consultation. Blood samples for NtproBNP and BNPwere collected and stored
frozen. Systolic HF was diagnosed in 48 patients (46% men, 54% women, mean age 79 years)
while 61 patients (21% men, 79% women, mean age 76 years) had no HF. We explored cut off
values for Nt-proBNP from 100 to 500 ng/L partly based on FDA recommendations. To
establish corresponding BNP cut-off values we analyzed the quotient between NT-proBNP/
BNP in patients with both systolic and diastolic HF who had the highest median levels.
This resulted in cut-off values for BNP from 10 to 50 pg/ml.
Results: Table 1. Shows results of the highest NPV, sensitivity, PPV and specificity for
NTproBNP and BNP including all 109 patients. In a linear regression analysis, Nt-proBNP
(b¼ 0,035; p<0,001) and BNP (b¼ 0,030; p<0,001) were associated with age, but not with
gender. In a multivariate analysis age (b¼ 0,036; p<0,001) and male gender (b¼0,270; p¼0,014)
were associated with Nt-proBNP, while age only significantly associated with increasing levels
of BNP (b¼ 0,030; p<0,001).
Conclusion: Natriuretic peptides in an elderly population showed high NPVs, but not as high as
in younger patients with HF in other studies. Age and male gender were associated with higher
levels of NT-proBNP while only age was related to BNP.
Table 1.
NTproBNP BNP
Cut-off level 200 ng/l 20 pg/ml
NPV 88% 87%
Sensitivity 96% 96%
Cut-off level 500 ng/l 50pg/ml
PPV 81% 68%
Specificity 87% 71%
P374
Human growth hormone and IGF-1 in risk stratification of patients with acute
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Background: Recently, an increasing number of new biochemical markers has been reported in
cardiovascular risk stratification. Clinical risk management of cardiovascular disease would
greatly benefit from event stratifying biomarkers. The aim of this study was to compare the
concentrations of growth hormone (GH) and insuline like growth factor-1 (IGF-1) in patients
with acute myocardial infarction (AMI) hospitalized in intensive care units compared with the
control group. Furthermore, authors assessed a possible correlation between the levels of GH
and IGF-1 and markers of myocardial necrosis troponin, and a correlation with left ventricular
ejection fraction measured on the seventh day after AMI.
Methods:We examined group of 35 patients in the age of 50-60 years with ST segment elevation
myocardial infarction (STEMI), defined as clinical manifestations of ischemia, ECG criteria and
positivity of cardiospecific enzymes. The control group consisted of 17 patients who were
admitted to the hospital for the differential diagnosis of chest pain. These patients had a normal
ECG record, negative cardiospecific enzymes, and (if indicated) a negative ergometric exam-
ination during hospitalization. For the determination of GH and IGF-1 concentration, blood was
collected in peracute phase of 4.5 hours 30 minutes after the chest pain had appeared followed
by the second specimen on the 7th day after AMI. Echocardiography was performed on the 7-th
day of hospitalization.
Results: When compared patients with AMI with control group, their GH levels were
significantly higher in peracute phase (1.42  0.25 vs. 0.48  0.07 ng/ml respectively,
p<0.001) and nonsignificantly higher on the 7th day after AMI (0.52  0.09 vs. 0.48  0.07
ng/ml respectively). In the group of patients with AMI, GH levels were about 2 to 3-fold higher
in peracute stage than on the 7-th day of AIM (1.42  0.25 vs. 0:52  0.09 ng/ml, p<0.01). GH
levels correlated positively with troponin levels in peracute phase (r ¼ 0.68159, p ¼ 0.0051) and
negatively with the values of ejection fraction measured on the 7th day after AMI (r¼ - 0.733747,
p¼ 0.0018). IGF-1 was positively correlated with left ventricular ejection fraction (r¼ 0.78741, p
¼ 0.0005).
Conclusion:Based on our data, we suggest that monitoring of the concentration of GH and IGF-
1 in peracute phase of AMI might be of clinical importance in risk stratification, early detection
of development of left ventricular dysfunction and eventually treatment monitoring.
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Heart Fatty Acid Binding Protein (h-FABP) is an optimal point of care diagnostic test
in early phase of non-ST elevation Acute Coronary Syndromes
M Rus, MI Popescu, AI Ardelean, C Costescu, EE Babes, VV Babes
University of Medicine and Pharmacy, Oradea, Romania
Topic: Biomarkers
Introduction: The heart-type specific Fatty Acid Binding Protein (h-FABP) is a small, cytosolic
protein (15 kDa) which may be useful for both rapid confirmation and exclusion of acute
myocardial infarction.
Objective: To determine the usefulness of a qualitative h-FABP rapid test (CardioDetect-med)
in a group of patients with acute coronary syndrome without persistent ST-segment elevation.
Method: In group of 100 (66 males, 34 females; 64 smokers) consecutive patients (mean age
61,66 years; median 62,5 years) with acute coronary syndrome without ST-segment elevation on
admission (median onset-to-door interval was 6 hours (range 1 to 24 hours); Ecg exam at
admission showed non ST-segment elevation (normal Ecg or ST depression or T wave
inversion) and without renal insufficiency and muscle injury.
Qualitative tests for serum h-FABP and quantitative for cardiac troponin I (cut-off value = 0.1 c¸g/
L) and CK-MB (cut-off value 24 U/L) were performed on admission and 3 hours later. The
ultimate diagnosis of NSTEMI was confirmed in case of a second positive result of cTnI
measurement. Each patient uderwent diagnostic coronarography to confirm level of coronary
artery stenosis.
Results: NSTEMI was finally diagnosed at 56 pts out of total 100 (56%). Diagnostic sensitivity,
specificity, positive, negative predictive value and accuracy on admission and after 3 hour for h-
FABP, CK-MB and cTnI are shown on the table.
Diagnosis enzyme
Results of cardiac
biomarkers
h-FABP ‘‘0’’ h-FABP ‘‘3’’ CK-MB ‘‘0’’ CK-MB ‘‘3’’ cTnI ‘‘0’’ cTnI ‘‘3’’
Sensitivity 94,64% 96,43% 67,86% 85,71% 66,07% 100%
Specificity 97,73% 97,73% 93,18% 95,45% 100% 100%
Positive predictive
value
98,15% 98,18% 92,68% 96,0% 69,84% 100%
Negative predictive
value
93,48% 95,56% 69,49% 84,0% 100% 100%
Accuracy 86% 97% 79% 90% 81% 100%
h-FABP - heart Fatty Acid Binding Protein, CK-MB - fraction MB of creatine kinase, cTnI - cardiac
troponin I.
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Does uric acid have a pathogenetic role in left ventricular remodelling and arrhyth-
mogenesis in patients after myocardial infarction ?
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Background: The role of serum uric acid (SUA) in the process of atherosclerosis and athero-
trombosis is controversial. Epidemiological studies have recently shown that SUA may be risk
factor for cardiovascular diseases and negative prognostic marker for mortality in subjects after
myocardial infarction.
Aim: To investigate the potential impact of SUA levels on left ventricular structural, functional
changes and arrhythmogenesis in patients after myocardial infarction.
Methods: 127 patients (59,20,8 years old) after myocardial infarction were included in cross-
sectional study. The subjects were divided in two groups with high and normal SUA level.
Echocardiographic assessment, Holter monitoring were performed.
Results: Patients with high SUA (n¼86) compared to those with low SUA (n¼41) had higher left
ventricular mass 6,9 vs 147,4index (220,90,01) and left atrial dimension (4,0<8,3, p0,5 vs
3,50,8, p<0,01), while did not differ in ejection fraction. Concentric and excentric hypertrophy
were observed in 58,1 % and 38,4 % patients with hyperuricemia, 26,8 % and 31,7% - with
normouricemia. Diastolic dysfunction was more often investigated in 0,01). SUA levels<pati-
patients with high SUA than with normal (94,2 % vs 36,6 %, p correlated significantly with mitral
E wave velocity (r¼0,61, p<0,01), E wave 0,05). There was no<0,01), E/A ratio (r¼0,21,
p<decelaration time (r¼0,26, p difference in frequency of atrial fibrilation and supraventricular
prematures in both groups, while high grade ventricular prematures according to Lown Wolf
were observed in 2,5 times more often in patients with high SUA. Also they had increased Q-T
dispersion more than 70 ms and decreased heart rate variability (SDNN less than 100 ms).
Involment of His-Purkinje system was more often observed in patients with hyperuricemia (74,4
% vs 26,8 %, p<0,01).
Conclusion: Elevated SUA level is associated with left ventricular hypertrophy and diastolic
dysfunction in patients after myocardial infarction, reflecting increased cardiovascular risk. Left
ventricular hypertrophy plays important role in arrhytmogenesis and along with hyperuricemia it
is a strong risk factor for future cardiac events as well as sudden cardiac death.
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Serial measurements of NT-proBNP in with unstable angina pectoris treated by
statins
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It is well known that brain natriuretic peptide (BNP) and N-terminal fragment (NT-proBNP)
levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and
may be useful to establish prognosis in heart failure, as both markers are typically higher in
patients with worse outcome. The plasma concentrations of both BNP and NT-proBNP are also
typically increased in patients with asymptomatic or symptomatic left ventricular dysfunction.
There is no strict level of BNP that perfectly separates patients with and without heart failure.
There are limited data on evolution of BNP/NTproBNP levels in unstable angina pectoris (UA).
HMG-CoA reductase inhibitors (statins) substantially improve clinical outcomes in pts with
CAD. Therefore, we tried to assess the clinical significance of serial measurements of serum
NT-proBNP in UA treated with different types of statins (Pravastatin and Atorvastatin).
Methods: 42 pts (14 female, aged 4621) with UA were involved in our study with follow up 20
weeks. In 24 hours after admission pts were randomized on Pravastatin (P) 80 mg/daily (Group P,
n¼20) or Atorvastatin 40 mg/daily (Group A, n¼22). All pts were on standard therapy (heparin,
aspirin, beta-blockers, nitrates, 33 were on ACE inhibitors). Total cholesterol (TCL) was
measured on admission and on 20 week. On 12 hrs and 24 hrs after admission blood samples
were collected for NT-proBNP.
Results: Serum NT-proBNP concentration was higher in Group P 1969 pg/ml [75-44775] than in
Group A 12339 pg/ml [776-41667], (p<0.03) after 12 hour and 1037 pg/ml [96-32345] vs. 11930
pg/ml [105-65022], p<0.01 after 24h. Unexpectedly, in the Group A NT-proBNP decreased
during first week of the treatment (p<0,001), while in Group P NT-proBNP remained at the
same high level. The primary end-point (a composite end-point of death, non-fatal MI,
rehospitalization for worsening angina at 20 weeks) was better in Group A: 13.8% vs.
18.54% (p < 0.05) but¨robust£ endpoints like death/MI were similar in both groups (11.2%
vs. 11.9%; p¼NS). The difference in the primary end-point was driven by rehospitalization for
recurrent angina (6.3% vs. 8.9%). During all follow up, TCL drops more significantly in Group A.
On the end of follow up TCL became normal in 10 pts (49.9%) in Group P and 16 (72.7%) in
Group A (p<0.03) without significant hepatic enzyme elevations.
Conclusion: Near normal NT-proBNP values or their rapid decrease within first 24 hrs of the
treatment of UA, indicate good prognosis, while persistent elevated NT-proBNP during
treatment suggests high-risk pts. A seems to be more preferable than P in pts with UA.
P378
Absorption and filtration apheresis columns lower LDL equally, but have different
effects on inflammatory biomarkers
A Hovland, RI Hardersen, TE Mollnes, KT Lappegard
Nordland Hospital, Bodo, Norway
Topic: Biomarkers
Purpose:Low density lipoprotein (LDL) apheresis is well established in hypercholesterolemia
otherwise uncontrolled. This treatment affects biomarkers of importance in atherosclerosis.
Hence we systematically compared three different LDL apheresis columns in this regard.
Methods:Three patients with heterozygous familial hypercholesterolemia participated in a
cross-over study with six concurrent treatments with three different LDL apheresis
columns:DL75 (whole blood adsorption), LA15 (plasma adsorption) and EC50W (plasma
filtration). Blood samples were drawn before and after treatment. A range of biochemical
parameters and inflammatory biomarkers,including LDL-cholesterol, high-sensitivity C Reac-
tive Protein (hs-CRP) and numerous cytokines, were compared. Due to inter-individual
variation, cytokine concentrations were normalized for evaluation of column effect.
Results:All three columns gave a 66-69% decrease in LDL. The reduction was highly significant
(p<0.001) without inter-column differences. Hs-CRP dropped 75%, 69% and 46% for columns
DL75, LA15 and EC50W,respectively (p<0.001 for all). Normalized changes in cytokines are
shown in the table below. Of notice is the considerable increase in IL-1ra and IP-10 with the
whole blood column DL75, and the decrease in TNF-a and VEGF with the adsorptive columns
DL75 and LA15. Other cytokines, including IL-6, showed less change. The column EC50W
induced a 13.3 fold increase in the anaphylatoxin C3abut left C5a-levels unchanged. The other
two columns gave a modest increase in C3a and a reduction in C5a.
Conclusions: The LDL-apheresis columns DL75, LA15 and EC50W all lowered LDL-
cholesterol significantly and to the same extent. Hs-CRP was also significantly reduced.
However,several cytokines with importance for coronary atherosclerosis including IL-1ra, IP-
10, MCP-1 and TNF-a were differently affected by the columns, as were the anaphylatoxins
C3a and C5a. This should be kept in mind in LDL-apheresis, as these patients are at high risk
for atherosclerotic events.
Selected cytokines
IL-1ra IL-6 IP-10 MCP-1 MIP-1b TNFa VEGF
DL75 2.2 1.1 2.6 0.9 0.7 0.4 0.3
LA15 1.8 1.4 2.3 1.8 1.4 0.4 0.3
EC50W 1.4 0.9 1.7 1.5 0.6 0.8 0.4
Normalized mean values of selected biomarkers after LDL apheresis with three different columns.
Pretreatment value ¼ 1, n¼18, p<0.05.
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The effects of depression on functional limitations in patients with chronic heart
failure
Y Shimizu1, S Yamada2, H Okumura1, Y Kono1, F Miyake3, T Izumi4
1Nagoya University Graduate School of Medicine, Program in Physical and Occupational
Therapy, Nagoya, Japan, 2Nagoya University, School of Health Sciences, Nagoya, Japan, 3St.
Marianna University School Medicine, Division of Cardiology, Kawasaki, Japan, 4Kitasato
University School of Medicine, Department of Cardio-angiology, Sagamihara, Japan
Topic: Cardiovascular rehabilitation
Objective: This study was aimed to examine the effect of depressive symptoms on the course of
functional limitations in patients with chronic heart failure (CHF) during recovering phase after
hospital discharge.
Methods: Data were obtained from the Preventive effect of exercise for management of daily
functioning in patients with CHF (PTMaTCH) study, a prospective cohort study. The Hospital
Anxiety and Depression Scale was used to evaluate the depression. Functional limitations were
measured by the Performance Measure for Activities of Daily Living-8 (PMADL-8) at 1, 3 and 5
months post-discharge. Relationships of functional limitations to demographic variables, bio-
physiological variables, physical function variables, and depressive symptoms were examined
with bivariate correlations and stepwise multiple regression analyses. Two-way repeated-
measures analysis of variance (ANOVA) was used to assess the effects of depressive symptoms
on the course of functional limitations. Using a cluster analysis, we identified classes charac-
terized by distinctive courses of functional limitations and then examined their link to
depression.
Results:A total of 254 subjects participated in the PTMaTCH study and the data of 148 subjects
who answered all the three points (1, 3, 5 months) were analyzed in this study. More than half
reported ‘‘somewhat hard’’ or ‘‘very hard’’ in each items (activities of daily living) of the
PMADL-8. Worse functional limitations was associated with a more severe depressive symp-
toms (r ¼ .46, P < .001) and lower grip strength (r ¼ -.40, P < .001). Depressive symptoms and
grip strength accounted for 33% of the variance in functional limitations at 5 months post-
discharge (P < .001). In two-way ANOVA, depressive symptoms significantly had the effect on
the course of functional limitations (F¼ 30.7, P< .001) but no interacted with time (F¼ 1.06, P
¼ .35). By the cluster analysis, 4 distinct courses were found and the class of subjects with stable
severe functional limitations had a significantly higher rate of depressive symptoms than all
other clusters (P < .001).
Conclusion: In our prospective study, depressive symptoms negatively affected the course of
functional limitations in patients with CHF. The findings of this study suggest that depression
may be a treatment target to improve functional limitations during recovering phase in CHF
patients.
P380
Psychosocial variables in adherence to cardiac rehabilitation program
DPGR Guerra Rosas Dinorah, ZL Lugli Zoraide
Simon Bolivar University, Caracas, Venezuela
Topic: Cardiovascular rehabilitation
Objective: To explore the predictive and discriminative ability of psycho-social variables on
different patterns of adherence to the cardiac rehabilitation program (CRP).Materials and
Methods: using a cross-sectional and comparative design, we evaluated 112 myocardial infarc-
tion (MI) survivor patients, referred for CRP from January 2005 through December 2007. The
patients were divided into three groups according to their pattern of adherence to CRP:‘‘begin
and finished’’ (Group I),‘‘begin and not finished’’ (Group II) and ‘‘never begin’’ (Group III).
Measured variebles were: Hostility, Coping Strategies, Social Support, Self-efficacy for
programmed and daily physical activity. Measurement instruments used were validated for
Venezuelan population.
Results: Discriminative analysis reveled that coping directed to the problem, perceived social
support and self-efficacy, were statistically significant for discriminating groups according to
their pattern of adherence to the CRP; while the variables hostility and emotional coping, were
not significant to explain the difference between the groups.
Conclusion: Hostility is a variable associated to cardiovascular disease but not relate to the
adherence behavior; rather, different levels of problem-focused coping, perceived social support
and self-efficacy, both programmed as daily, predicted belonging to the group. Clinicians staff
must to considerate to training this variables to ensure the adherence to CRP.
P381
Overcoming the barriers; increasing completion rates of indigenous cardiac rehabi-
litation through partnership
S M StewartEadie1, M Tane2
1National Heart Foundation of New Zealand, Auckland, New Zealand, 2Te Hotu Manawa
Maori, Auckland, New Zealand
Topic: Cardiovascular rehabilitation
Background: Cardiovascular disease in New Zealand s indigenous Maori is associated with
significant inequalities, with mortality rates for those under 65 being more than four times that of
mainstream for the same age. Furthermore those that do survive a myocardial infarction are less
likely to receive the benefit of cardiac rehabilitation, with attendance and completion rates being
half that of mainstream, by percentage of the population. To help readdress this, the Heart
Foundation of New Zealand and the Maori equivalent, Te Hotu Manawa Maori partnered
together to develop a new home based cardiac rehabilitation programme for both mainstream
and Maori, called Heart Guide Aotearoa.
Method: A quantitative and qualitative study was developed to evaluation whether the new
model of cardiac rehabilitation would significantly increase uptake and completion of cardiac
rehabilitation. 413 participants were enrolled from seven sites, and the results would be
compared to an earlier audit of traditional hospital based cardiac rehabilitation services.
Results: Heart Guide Aotearoa resulted in lowering the barriers previously experienced by
Maori with completion rates increasing from 21% to 89%. The mean age of those attending also
demonstrated improvement falling from 66 years to 58 years old. These results were further
reinforced by the qualitative arm of the study that suggested the programme removed the
barriers of travel, cost, and illness that often prevent hospital based patients from seeking or
completing cardiac rehabilitation. Furthermore many HGA clients demonstrated that they were
more able to take control of their condition. They were less fearful and depressed about their
future as demonstrated by Hospital Anxiety and Depression Scores and had made a number of
positive lifestyle changes.
Summary: This demonstrated that together mainstream and indigenous stakeholders can come
together to develop a new and sustainable model of care that helps overcome many of the
barriers previously experienced, especially for indigenous Maori. The success of this programme
has resulted in the programme being increasingly rolled out across New Zealand and being
offered to both mainstream and Maori alike.
P382
Cardiovascular rehabilitation benefits on anxiety and depression scores in patients
after valve replacement
M Rada, DV Velimirovici, DMDS Duda-Seiman, SD Dragan, DG Gaita, MBV
Berceanu-Vaduva, MDV Velimirovici, SM Mancas
University of Medicine and Pharmacy Victor Babes Timisoara, Timisoara, Romania
Topic: Cardiovascular rehabilitation
Purpose: Anxiety and depression are frequent in patients with history of surgery and are more
acute in those with decreased functional reserve. We assessed the influence of comprehensive
rehabilitation programme on the anxiety and depression score in patients after valve replace-
ment, depending on gender.
Methods: 73 patients with valve replacement: 46 (63.01%) men, 27 (36.98%) women, mean age:
587 years. We considered 2 groups: group A: 38 patients with exercise training programme;
group B: 35 patients control. All patients had a complete clinical and paraclinical assessment at
admission. HAD scale was used to assess the anxiety-depression score, both at admission and
after 3 months (after phase II of rehabilitation). The HAD scale was used to assess the anxiety-
depression score, with the following interpretation: 0-7 no anxiety and/or depression; 8-10: low
anxiety and/or depression; 11-14 moderate; 15-21: severe. Patients in group A had a regular
exercise training program 3 times/week, 30-40 min/meeting to 70-75% from the achieved heart
rate at the effort test.
Results: In group A there was noticed a significant improvement both in anxiety and in
depression scores (anxiety incidence was higher). Comprehensive rehabilitation programmes
led to an improvement of pathologic anxiety: group A: 6.21.1 after phase II vs. 11.11.5 at
baseline (<0.01); group B: 6.71.3 after phase II vs. 11.31.6 at baseline (<0.05).
Depression score was improved more obvious in group A: 5.20.6 after phase II vs. 12.21.4 at
baseline (<0.05).
Conclusions: Anxiety is more frequent than depression in patients after valve replacement.
Comprehensive cardiac rehabilitation programmes, where exercise training and psychological
counseling play a key role, lead to effort capacity increase and improvement of the anxiety-
depression score. Men appear to be a protective factor against anxiety.
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TheCHARMSStudy: Cardiac rehabilitation staff views about discussing sexual issues
with coronary heart disease patients: a national survey in Ireland
S Doherty1, M Byrne1, HM Mcgee2, AW Murphy1
1National University of Ireland, Galway, Ireland, 2Royal College of Surgeons in Ireland, Dublin,
Ireland
Topic: Cardiovascular rehabilitation
Background: While a healthy sexual life is regarded as an important aspect of quality of life,
sexual counselling from healthcare providers for cardiac patients has received little attention in
the literature.
Aim: To document current practice and assess the needs of cardiac rehabilitation service
providers in Ireland with regard to sexual assessment and management for patients.
Methods: Cardiac rehabilitation staff in all relevant centres in Ireland responded to a postal
questionnaire. Sexual health management was assessed by a series of questions on current
practice, and staff attitudes, beliefs and perceived barriers to discussing sexual problems.
Results: Staff (N¼60;61% response rate) reported a lack of assessment and counselling protocols
for addressing sexual health problems, with little or no onward referral system available. Results
also suggest staff believe that patients don t expect them to ask about their sexual concerns.
Barriers reported included an overall lack of confidence (45%), knowledge (58%) and training
(85%).
Conclusion: Development of guidelines, assessment protocols and training for cardiac rehabi-
litation staff are essential in the area of sexual health problems in order to improve the quality of
services for patients with coronary heart disease.
P384
MI patients intentions to attend cardiac rehabilitation programmes, a quantitative
survey
G Mckee1, S O Donnell1, M Mooney1, F O Brien1, D Moser2
1Trinity College, Dublin, Ireland, 2University of Kentucky, Lexington, United States of America
Topic: Cardiovascular rehabilitation
National guidelines recommend that all eligible patients be invited to partake in rehabilitation
programmes. The literature cites the numerous reasons patients give as to why they do not want
to attend cardiac rehabilitation programmes. These include: gender, transport problems, co-
morbidities psychological reasons, poor motivation and work commitments.
Purpose: To ascertain the proportion of patients who intend to attend Phase III cardiac
rehabilitation To describe the reasons why patients do not intend to attend Phase III cardiac
rehabilitation programmes
Methods: This study is part of a larger project based in five major academic teaching hospitals.
Patients admitted to hospital with ACS symptoms and who fulfilled the eligibility criteria were
invited to take part in the study. Each participant then completed an in-depth questionnaire
which contained items related to their current cardiac condition. Two of these items were
related to the participants intention to attend cardiac rehabilitation and these findings are
presented here. Data were analysed using SPSS.
Results: The sample demographics were, age 62.18þ 11.86 years, 68% male, current diagnosis:
44% STEMI, 56% NSTEMI. A total of 1341 patients participated in the study, 1292 completed
the question, 1004 (78%) stated that they intended to go to cardiac rehabilitation and the
remaining 288 (22%) stated that they did not. The following are the main reasons stated for non
attendance: not interested 40%, programme would be of no assistance 11%, previously attended
10%, not yet discussed 9%, difficulty with transport 6%, work or time difficulties 6%.
Conclusions: It was reassuring to note that 78% of patients planned to attend a cardiac
rehabilitation programme. The reasons given for not wishing to attend cardiac rehabilitation
are clinically very significant. Given the obvious benefits of such a programme for cardiac
patients, in relation to education, counselling, exercise, recovery etc it is important that
programme co-ordinators are cognisant of everyday issues that may impact on the individuals
intention to attend Some of the reasons cited such as ‘‘uninterested’’ and the ‘‘programme would
be of no assistance’’, leave room for further discussion with a cardiac rehabilitation team
member. They could encourage, motivate, reinforce the advantages of cardiac rehabilitation and
indicate even more clearly that it is not just about exercise and that all aspects of the programme
are individualised and autonomous.
P385
Cardiopulmonary exercise training in patients with ischemic heart disease: systolic
function and quality of life
J Siegelova, J Pochmonova, L Mifkova, L Vymazalova, A Havelkova, L Konecny, P
Vank, B Fiser
Masaryk University, Faculty of Medicine, Brno, Czech Republic
Topic: Cardiovascular rehabilitation
Purpose of the study: The aim of the present paper was to study oxygen transport system, work
load and quality of life in two groups of patients with ischemic heart disease (group with ejection
fraction EF>40% and group with EF<40%) before and after twelve weeks lasting exercise
training.
Methods: Seventy one patients with ischemic heart disease with ejection fraction EF>40% (EF
mean value 537%), body mass index BMI 282 kg.m-2, mean age 6110 years, and 17 patients
with EF<40% (EF mean value 337%), body mass index BMI 285 kg.m2, mean age 668
years were examined. Symptom-limited spiroergometry was provided before and after exercise
training, which consisted of warmup period, aerobic training, resistance training and cool-down
period (twelve weeks 3 times per week). We evaluated capacity of oxygen transport system
(VO2SL ml.min1, VO2SL.kg1 ml.min1.kg1), maximal reached load symptom-limited
(WmaxSL W, WmaxSL.kg1 W.kg1) and, using Seattle Angina Questionnaire (SAQ 1-5),
subjective estimation of quality of life.
Results: In the group with EF>40% we have found (before versus after) significant change of
WmaxSL (115.634.0 v. 124.436.2, p<0.01), WmaxSL.kg1 (1.40.4 v. 1.450.43, p<0.01)
VO2SL (1739422 v. 1862444, p<0.05), VO2SL.kg1 (20.44.9 v. 21.85.3, p<0.05), SAQ1
(78.818 v. 8422, p<0.01) SAQ2 (7622 v. 8516, p<0.01) SAQ3 (8815 v. 938, p<0.01),
SAQ4 (8815 v. 948, p<0.01), SAQ5 (6516 v. 7416, p<0.01). In the group with EF<40%
we have found WmaxSL (97.222.7 v. 112.230.9), VO2SL (1510320 v. 1718416, p<0.05),
VO2SL.kg1 (17.94.0 v. 20.76.6, p<0.05). The values of SAQ have not been changed
significantly: SAQ1 (8316 v. 8614), SAQ2 (8517 v. 8814), SAQ3 (8712 v. 9110), SAQ4
(8718 v. 9015), SAQ5 (7120 v. 7521).
Conclusion: Twelve weeks lasting exercise training increased oxygen transport capacity and
work load in both groups of patients with ischemic heart disease. The quality of life after
exercise training was improved only in the group with EF 537%, in the group with EF 337%
it was not changed.
P386
Comparison of a questionnaire to assess anxiety and depression among executives
and non-executives and the cardiovascular reactivity to mental stress
A Coimbra1, RRT Castro2, A Arantes3, R Cruz3, A Leal3, F Varzim3, M Andrade3,
ACL Nobrega4
1FAPES/BNDES - Hospital Pro´ cardiaco, Rio de Janeiro, Brazil, 2Instituto Nacional de
Traumatologia e Ortopedia, Rio de Janeiro, Brazil, 3FAPES/BNDES, Rio de Janeiro, Brazil,
4Hospital Pro´ cardiaco, Rio de Janeiro, Brazil
Topic: Occupational health
Purpose: Working environments has been the subject of research related to stress and there
seems to be differences between the level of stress and anxiety among employees at different
levels. Our study investigated the relationship between the answers to a validated questionnaire
to measure subjective anxiety and depression and the hemodynamic responses to a validated
test for measuring cardiovascular reactivity to mental stress among executives and non-execu-
tives of a large company.
Methods: Healthy subjects (n¼156) who were not taking any medication were submitted to a
questionnaire with 14 questions about anxiety and depression and to the Stroop color test with
auditory conflict, where they had to identify the changing color of words on a computer screen
while other color names are being pronounced through headphones and a standard arithmetic
test. Electrocardiogram was continuously and digitally monitored trought the tests. Also, non
invasive and intermitent blood pressure with digital esfignomanometer was registered. Subjects
were divided in two groups: normal response to mental stress test (N) and exacerbated response
(E). Subjects with an increase of heart rate> 15bpm and/or increase in systolic blood pressure>
25mmHg and/or increase in diastolic blood pressure > 15mmHg were included in the E group.
Results: the results were compared between executive and non-executives who had normal
response to the questionnaire (n ¼ 109) and those who had abnormal response in the
questionnaire (n ¼ 47), suggesting anxiety or depression (x2 ¼ 0.13). We did not observe
correlation between executives and anxiety (x2 ¼ 0.28). When compared in relation to the
hemodynamic response to mental stress test, we don t found significant correlation between
executives or not (x2¼ 0,28).
Conclusion: The subjective level of anxiety or depression or the position as executive or non-
executive in a large company does not seem to predict the cardiovascular response to simulated
mental stress, suggesting that the objetive measurement of this response should be performed in
order to identifiy exaggerated responders.
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Prevalence, determinants and prognostic significance of type D personality in elderly
patients with stable CAD and normal NT-proBNP levels
J H A J De Sutter, N Van De Veire, J Philippe, M De Buyzere
Ghent University, Ghent, Belgium
Topic: Psychosocial factors and stress
Background and study aims:Type D personality has been proposed as a marker of poor outcome
after acute myocardial infarction and in patients with chronic heart failure (CHF). It has also
been associated with increased levels of markers of inflammation. Its prevalence, determinants
and prognostic significance in elderly patients with stable CAD without CHF has not been
studied in detail and is the aim of the present study.
Methods:We prospectively enrolled 176 patients older then 60 years (mean age 716 years, 22%
women, LVEF 5913%) with stable CAD (> 6 months after AMI or revascularisation) and NT-
proBNP levels < 450 mg/dl. Type D personality was assessed according to the questionnaire
developed by Denollet. All patients underwent baseline echocardiography, a maximal spir-
oergometry for evaluation of VO2max and a 6 minutes walking distance (6 min WD). The
following markers of inflammation were determined: high sensitivity CRP (hsCRP), tumour
necrosis factor (TNF) soluble TNF receptor I and II (sTNFrecI and II), and interleukin-6 (IL-
6). The Minnesota questionnaire was used as measurement of quality of life (QOL). Patients
were followed for a median follow-up of 32 months for the combined endpoint of death, acute
myocardial infarction, PCI, CABG and hospitalization for CHF.
Results: In total 38 patients (22%) had type D personality according to the criteria of Denollet.
Their QOL was clearly worse (Minnesota QOL 4122 vs 2119, p<0.01). Age, gender, diabetes
and cardiovascular medication use were comparable between pts with and without type D
personality (all p>0.05).
Also LVEF (5712% vs 6013%,p¼ns), creatinine (0,930,17mg/dl vs 0,980,18mg/dl,p¼ns)
and NT-proBNP levels (160104 pg/ml vs 161110 pg/ml, p¼ns) were comparable. All markers
of inflammation were also comparable (p>0.05 for hsCRP, IL-6, TNF and sTNFrecI and II) as
well as measurements of exercise capacity (VO2max 16,75,3 vs 17,25,3 ml/kg/min, p¼ns, 6
minWD 450109 m vs 44399 m, p¼ns).
During follow-up 26pts developed cardiac events. Type D personality was not associated with
events in univariate and multivariate Cox proportional regression analysis. Event rates were
comparable between patients with and without type D personality (Kaplan-Meier Log Rank
Chi-Square 0,47, p¼0.49)
Conclusions: In elderly patients with stable CAD and normal NT-proBNP levels, type D
personality was present in 22% of patients and was associated with a poor quality of life. It was
however not associated with parameters of LV dysfunction, increased inflammation or decreased
exercise capacity and it did not predict cardiovascular outcome.
P390
Type D personality in patients with multifocal atherosclerosis: prevalence and influ-
ence on quality of life
A N Sumin, OI Raih, EV Korok, AV Karpovich, JAE Bohan, OL Barbarash
RAMS Scientific-Research Institute for Complex Studying of Cardiovascular Diseases, Kemerovo,
Russian Federation
Topic: Psychosocial factors and stress
Purpose: The presence of Type D ("distressed") personality is accompanied by the prognosis
deterioration in coronary artery disease (CAD) and peripheral arterial disease (PAD). However
type D personality did not study at patients with carotid disease (CS) and multifocal ischemic
pathology.
The aim of the study was evaluate the prevalence of type D personality and its influence on
quality of life (QOL) in patients with multifocal atherosclerosis.
Methods: The study included 499 patients (age 60,77,3 years) who were admitted to the
hospital for carotid endarterectomy, peripheral arterial reconstruction or coronary artery bypass.
All patients were subjected to color duplex examination of the carotid vessels and to lower
extremity Doppler study. Coronary angiography was performed on patients with PAD and CS.
The patients were divided into 4 groups: group CAD (n¼220), group CADþCS (n¼122), group
CADþPAD (n¼78), and group CADþCSþPAD (n¼79). Type D personality was measured
with the 14-item Type D Personality Scale (DS14). The Short-Form Health Survey 36 (SF-36)
was used to assess QOL. The depression scale was used to evaluate depressive symptoms.
Results: (see table). Subscales rates of Type D were higher in the patients with multifocal
ischemic pathology. Type D personality was the least often met among CAD group and the most
often among patients with coexistence CAD, CS and PAD. Also QOL and depression level were
lower in multifocal atherosclerosis in comparison with the isolated CAD.
Conclusion: High prevalence of Type D personality in patients with multifocal ischemic
pathology was associated with the deterioration QOL and high level of depression.
Type D in multifocal atherosclerosis
Variables CAD
(n¼220)
CADþCS
(n¼122)
CADþPAD
(n¼78)
CADþCSþPAD
(n¼79)
p
Type D (n,%) 24 (10.9%) 28 (22.9%) 28 (35.9%) 30 (37.9%) 0.0001
NA 7.40.2 9.20.5 10.60.9 10.20.6 0.0001
SI 7.80.2 9.50.5 10.70.9 10.20.5 0.0001
GH 72,71.4 53.82.4 36.73.5 32.52.3 0.0001
PF 75.21.3 58.32.4 38.63.4 36.12.8 0.0001
SF 58.51.4 49.61.8 39.03.3 43.32.6 0.0001
Depression 46.9  0.5 55.2  0.7 57.6 1.6 62.7  0.8 0.0001
NA - Negative Affectivity, SI - Social Inhibition (subscales of DS-14), GH - General health, PF
Physical functioning, SF - Social functioning (subscales of SF-36)
P391
Cardiovascular safety of 1-year escitalopram therapy in clinically nondepressed
patients with acute coronary syndrome: results from the DECARD tria
J A Hanash, B H Hansen, J F Hansen, O W Nielsen, A Rasmussen, M Birket-Smith
Bispebjerg Hospital of the Copenhagen, University Hospital, Copenhagen, Denmark
Topic: Psychosocial factors and stress
DECARD study group
Background: Selective serotonin reuptake inhibitors (SSRIs) are commonly used for treatment
of depression in patients with cardiac diseases. However, evidence of cardiovascular (CV) safety
from randomized trials is based on studies of no longer than 6-month duration. We examined the
effect of 1-year SSRI escitalopram therapy on multiple CV safety domains in nondepressed
patients with recent acute coronary syndrome (ACS).
Methods: The DECARD (DEpression in patients with Coronary ARtery Disease) trial assessed
the prophylactic effect of escitalopram on depression after ACS. 240 patients were randomised to
either escitalopram 10 mg or matching placebo for one year. Serial measures of CV safety
including clinical and biochemical parameters, 24-h ECG monitor, resting ECG and echocar-
diographic assessment were obtained.
Results: Escitalopram and placebo-groups were comparable at baseline with regard to age,
gender, sociodemography, depression score, risk factor profile, severity of heart disease and
medications. Dropout rates defined as withdrawal for any reason or lost to follow-up during the
12-month study period was 27.2% in the escitalopram group and 23.4% in the placebo group
(NS). There were no statistically significant differences between intervention groups in any of
CV safety measures including the incidence of ventricular arrhythmia and episodes of ST-
segment depression, length of QTc, and systolic and diastolic echocardiographic measures at the
12-month follow-up between groups. After 12 months, 16 and 13 major adverse events (death,
recurrent ACS or acute revascularisation) were recorded in the escitalopram and placebo group,
respectively (NS).
Conclusion: One-year escitalopram treatment was safe and well-tolerated in patients with
recent ACS.
P392
2 year follow up of patients diagnosed with Non Cardiac Chest Pain (NCCP) attending
the Rapid Access Chest Pain Clinic (RACPC) in a single tertiary centre
S Kasim, J Groarke, B Walsh, J Crowley
University Hospital Galway, Galway, Ireland
Topic: Psychosocial factors and stress
Background: RACPC have been introduced to expedite investigations of patients suspected of
having cardiac chest pain by their general practitioners. Many continue to report symptoms
despite normal investigations.
Objective: We aim to report on the outcome at two years on patients diagnosed with NCCP and
the impact to their lifestyle and the healthcare system.
Methods: Patients referred to the RACPC between January 2004 and April 2006 in University
College Hospital Galway was enrolled. Demographics and risk factor profile were obtained from
clinical records during attendance to the service. Patients who proceeded to diagnostic coronary
angiography after assessment and subsequently diagnosed with non cardiac chest pain were
followed up. Follow up was performed via telephone questionnaire that has been validated in
previous studies.
Results: 167 patients (female¼102, 61%) were identified with normal angiograms after assess-
ment in RACPC. Mean age was 57years old. Risk factors were smokers (25%), hypertension
(40%), diabetes (5%) and hypercholesterolemia (34%). At 2 years, 97 patients (58%) continue to
report similar symptoms to initial presentation. 48% had symptoms lasting for more than a year.
6.9% report limiting symptoms despite a normal angiogram and up to 23% believed that their
symptoms are due to cardiac. No specific diagnosis was made in 34% of 167 patients. Half of
these continued to have symptoms on a daily basis. Up to 30% of patients attended their GP
more than once. 12patients in the non specific diagnosis group attended the Emergency
Department more than once with their symptoms resulting in 6 in patient bed days despite
normal angiogram.
Conclusions: A diagnosis of NCCP failed to alleviate symptoms in a significant number of
patients attending the RACPC. These patients should be identified and a pathway constructed
to reduce the amount of inappropriate resource utilisation to the healthcare system.
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Type D personality and prevalence of cardiovascular risk factors in subjects without
established cardiovascular disease
G Einvik1, H Hrubos-Strom2, A Randby3, SK Namtvedt3, HK Kristiansen3, T Dam-
men2, T Omland3
1Akershus University Hospital, Department of Medicine, Lorenskog, Norway, 2University of Oslo,
Department of Behavioural Sciences, Oslo, Norway, 3University of Oslo, Faculty Division,
Akershus University Hospital, Oslo, Norway
Topic: Psychosocial factors and stress
Purpose: Type D personality has been associated with poor cardiovascular outcome in patients
with coronary heart disease. However, there is few data on the role for type D personality in
primary development of cardiovascular disease. We investigated whether type D personality was
associated with the prevalence of cardiovascular risk factors in subjects without overt cardio-
vascular disease.
Methods: From an epidemiological survey on symptoms of sleep apnea (Akershus Sleep
Apnea Project) 1350 persons were invited to a clinical study, out of whom 535 (39%) were included,
437 without established cardiovascular disease. Type D personality was assessed with DS14. A
cardiovascular risk score was calculated by adding the presence or absence of the following
risk factors: Hypertension (>140/90 or treatment), diabetes (glucose >7mmol/l or treatment),
obesity (BMI25 or waist >102cm men, >88cm women), hyperlipidemia (total cholesterol
>5mmol/l or LDL-cholesterol >3mmol/l), current smoking and low physical activity (regular
exercise <3h/week).
Results:PersonswithtypeDpersonalityhadasignificantlyhighercardiovascularriskscore(figure1),
due to higher prevalence of smoking and low physical activity (table 1).
Conclusion:Type D personality may be associated with clustering of cardiovascular risk factors in
subjects without established cardiovascular disease.
Table 1. Prevalence (%) of cardiovascular risk factors
Hypertension Diabetes Obesity Hyperlipidemia Smoking Low physical
activity
Non-type D 49 30 75 83 21 40
Type D 49 25 82 86 43 57
50%
40%
30%
20%
10%
 0%
0
Number of cardiovascular risk factors
Total burden of cardiovascular risk factors for 
type D vs non-type D subjects 
1 2 3 4 5 6
Non-type D Type D
Mannwhitney U-test P = 0.001
P394
Mind your mind: lack of introspective insight predicts lower heart rate variability in
post-myocardial infarction patients
I Nyklicek1, EJ Martens1, BM Szabo1, J Denollet2
1Tilburg University, CoRPS Center of Research on Psychology in Somatic Diseases, Tilburg,
Netherlands, 2St. Elisabeth Hospital Tilburg, Department of Cardiology, Tilburg, Netherlands
Topic: Psychosocial factors and stress
Purpose: Introspective insight is insight into one s internal psychological states and processes as
a result of being able to reflect upon these phenomena. It is hypothesized to lead to more
adaptive behavior in general, including health-promoting behavior, resulting in a better
hemodynamic function. We examined the association between introspective insight and heart
rate variability (HRV; an important marker of cardiovascular function and prognostic factor) in
post-myocardial infarction (MI) patients.
Methods: This study included 82 post-MI patients (82% men, mean age¼ 56 10 years). All
patients completed the Lack of Psychological Mindedness scale (Denollet & Nyklicek, 2004)
scale, measuring lack of insight, and had a Holter ECG recorder for 24 hours. Both time and
frequency domain measures of HRV were obtained.
Results: Patients with a lack of introspective insight showed a tendency for lower HRV across
both time and frequency domain measures. After adjustment for sex, age, medication, and
disease severity (multi-vessel disease and anterior infarction), significance was retained for
vagally mediated time domain measures (rMSSD and pNN50) and for low frequency spectral
power (F > 4.22, p< .05). Nonsignificant trends in the same direction were obtained for the
vagally mediated high frequency spectral power, the very low frequency power, as well as the
overall time domain measures SDNN and SDANN (F > 3.29, p< .08).
Conclusions: Lack of introspective insight was associated with lower heart rate variability in
post-MI patients. Future studies should examine whether a lack of introspective insight is also
associated with an increased risk of adverse clinical events in post-MI patients.
Low Insight High Insight p
VLF 25.7 (1.5) 29.5 (1.6) .054
LF 14.5 (1.5)  17.9 (1.5)  .039
HF 10.3 (0.9) 12.2 (0.8)  .074
rMSSD 25.4 (1.9)  31.4 (1.9)  .013
pNN50 6.5 (1.3)  9.7 (1.2)  .043
SDANN 96 (5.7)  109 (6.1)  .077
SDNN 111 (6.1)  127 (6.5)  .052
Means (SD) of HRV indices by level of introspective insight
P395
Prevalence of depressive symptoms and low social support level in Polish obese
persons. Results of WOBASZ Study
J Piwonski1, E Sygnowska1, A Piwonska1, W Drygas2, T Zdrojewski3, J Gluszek4, A
Pajak5, K Kozakiewicz6
1National Institute of Cardiology, Warsaw, Poland, 2Medical University, Lodz, Poland,
3Medical University, Gdansk, Poland, 4Poznan University of Medical Sciences, Poznan, Poland,
5Jagiellonian University, Cracow, Poland, 6Medical University of Silesia, Katowice, Poland
Topic: Psychosocial factors and stress
WOBASZ group
Purpose: Negative psychosocial risk factors can be both risk factors of obesity due to their effect
on person s behaviour as well as they can be a result of being obese because of the lack of
acceptance obese persons by family or population. We want to evaluate the prevalence of
depressive symptoms and low social support level in obese persons in comparison to the rest of
population.
Methods: Data came from the representative sample of polish population - 6392 men and 7153
women, aged 20-74, examined in 2003-2005 in the frame of National Multicenter Health Survey
(WOBASZ). Study procedure covered questionnaire (socio-demographic data, habits, medical
history, psychological questionnaires), physical examination and laboratory tests. Depressive
symptoms were assessed using Beck s depressive scale and social support using Berkman and
Syme questionnaire.
Results: 1313 men -M (21%) and 1612 women - W (22%) were obese. Obese persons were older
and independently of age had higher levels of risk factors. Both men and women with obesity In
comparison to persons without obesity significantly more often had depressive symptoms (M
29% vs 22%, p< 0.0001; W 46% vs 30%, p< 0.0001). Lack or low social support were observed in
58% of obese M and in 79% obese W (In comparison respectively to 64% M and 68% W without
obesity). There was observed the significant association between obesity and depressive
symptoms and low social support level, both in men and women. In obese, compared to not
obese men, the chance of getting depressive symptoms (independently of age) was higher by
14% (OR¼1.14, p<0.05), and in women even by 40% (OR¼1.40, p<0.0001). In obese man the
chance of getting low social support level was lower by 29% (OR¼0.71, p¼0.0014), but in women
increased by 19% (OR¼1.19, p<0.05) compared to not obese persons.
Conclusions: In obese persons, both men and women, depressive symptoms were observed
more often than in persons without obesity, but low social support were observed more often
only in obese women.
P396
Lifestyle intervention, quality of life and cost-effectiveness, a randomized controlled
trial
MK Eriksson1, EB Malmgren-Olsson2, LA Hagberg3, M Eliasson4
1Bjo¨rkna¨s Health Care Center, Boden, Department of Community Medicine and rehabilitation,
Umea, Sweden, 2Department of Community medicine and rehabilitation, Umea, Sweden, 3Centre
for Health Care Sciences, Orebro County Council, Orebro, Sweden, 4Department of Medicine,
Sunderby Hospital, Lulea, Department of Public Health and Clinical Medicine, Lulea, Sweden
Topic: Quality of life
Background and Purpose: Individuals with obesity, diabetes and other cardiovascular risk factors
report diminished well-being and quality of life (QOL). Lifestyle interventions reduce cardi-
ovascular risk and delay onset of diabetes, but reports on QOL are rare. For complete evaluation
of an intervention program it is essential to incorporate the patient s perspective of physical,
mental and social well-being. Also cost-effectiveness analysis relies heavily on valid QOL
measurements. The effect of a lifestyle intervention in an ordinary primary care setting on
health-related quality of life (QOL) and cost-effectiveness was assessed.
Methods:A total of 151 middle-aged men and women at moderate to high risk for cardiovascular
disease were randomly assigned to either a lifestyle intervention or standard care. The 3-month
intervention period was administrated in the primary care setting and consisted of supervised
exercise sessions and diet counseling, followed by regular group meetings during 3-yr. Partici-
pants were followed-up at 3, 12, 24 and 36 months. Outcomes were change in QOL measured
with the use of EuroQol and 36-Item Short Form Health Survey (SF-36), and SF-6D, and
change in motivational stage for physical activity. In a cost-utility analysis the costs, gained
quality-adjusted life years (QALY) and savings in health care and were considered. Probability
of cost-effectiveness was also described using Net Monetary Benefit Method.
Results: Lifestyle intervention significantly increased EQ Rating scale (p<0.01), and SF-36
physical functioning, bodily pain (less pain), physical component summary (p<0.05) and SF-6D
(p<0.01) over the 3-yr period and at time point 3-yr. Standardized response mean (SRM) showed
a moderate effect. No significant improvement was seen in EQ-5D or in SF-36 mental
dimensions after 3-yr but SRM indicated small effects. More participants in the intervention
group progressed to active stages of change for physical activity during the 3-year follow-up
(p<0.001). There was a net saving of 47 USD per participant. Cost per gained QALY, savings not
counted, were 1668-4813 USD. Probabilities of cost-effectiveness were 89-100% when 50 000
USD was used as threshold of willingness to pay for a gained QALY.
Conclusion: A lifestyle intervention in primary care improves several dimensions of QOL and
motivation for physical activity, up to 3 years. The intervention method was highly cost-effective
in relation to standard care.
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Tai chi added to endurance training vs endurance training alone in elderly patients
with chronic heart failure: a randomized pilot study
G Caminiti, M Volterrani, A Arisi, A Cerrito, R Massaro, S Bovone, A Carluccio, G
Rosano
IRCCS San Raffaele Pisana Hospital, Rome, Italy
Topic: Quality of life
Purpose: To asses if Tai Chi added to endurance training (ET) is more effective than ET alone
in improving exercise tolerance and quality of life of elderly male patients with chronic heart
failure (CHF).
Methods: Twenty-seven male CHF patients, age 73þ/6 years; ejection fraction 33þ/9,
NYHA II-III were enrolled. Eleven pts were randomized to combined training (CT) group
performing Tai ChiþET and 10 patients to ET group (ET only). At baseline and after 12 weeks
all patients underwent 6-minute walking test (6MWT), assessment of quadriceps maximal
voluntary contraction (MVC) and peaktorque (PT) blood pressure and heart rate (HR). Tai Chi
and ET were both performed 3 times/week
Results: Exercise was well tolerated. No patients had adverse events. Distance at 6mwt
improved in both groups (CT group: 1280þ/32m; ET group:96þ/23 m) with significant
intergroups differences (p 0.041). Rest HR significantly decreased in the CT group while
remained unchanged in the ET group (9 bpm vs 3 bpm, p 0.03). Patients of the CT group had
a greater significant improvement in social and emothional QOL than ET group (between
groups differences: þ8%, p 0.01; þ6%, p 0.03 respectivelty). Patients of CT group had a no
significant higher increase of both MVC and PT than ET group.
Conclusions: Tai Chi added to ET, significantly improves exercise tolerance and QOL of
patients with CHF.
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Blood pressure response to exercise in young athletes associated with classification
of sports
N M Nicole MPanhuyzen-Goedkoop1, R Terink2, JLRM Smeets1
1Radboud University Nijmegen Medical Centre, Heartlung Centre, Nijmegen, Netherlands,
2Sports Medical Center Papendal, Arnhem, Netherlands
Topic: Sports cardiology
Purpose: hemodynamic responses to maximal exercise testing cover the general population.
Bloodpressure (BP) responses in athletes are reported at rest and during ambulatory BP
monitoring. BP responses associated with different classes of sports are lacking.
Purpose: To determine BP responses to exercise related to different classes of sports in young
athletes (=35yr).
Methods: Young athletes who had pre-participation cardiovascular screening, maximal exercise-
ECG, and were engaged in regular physical training and competition > previous 6 month were
included in this retrospective study during 2000-2008. Bicycle exercise protocol until exertion,
75 watt (men) or 50 watt (women) during 4min, increment 25 watt / 2 min. BP and ECG at rest,
each increment, and recovery phase was measured manually.
Results: 475 athletes were included, 308 men and 167 women, age 9-35yr (mean 24yr). Number
of training hours 1-30/wk. Mean resting BP was 122 mmHg systolic and 73.5 mmHg diastolic.
Mean resting heart rate was 61.7 bpm on ECG. Mean BP responses to maximal exertion in
different classes of sports (mmHg) are in table.
Conclusion: this is the first study that demonstrates different BP responses associated with
different classes of sports. The highest systolic and diastolic BP responses were recorded in
moderate static-low dynamic sports. The lowest diastolic BP responses were recorded in
moderate static-high dynamic sports. Values above the criteria for hypertension on exertion
were in moderate static-low dynamic and high static-low dynamic classes of sports. Further
studies are warranted to define ‘‘normal’’ blood pressure response to exercise in different classes
of sports
Mean BP responses to maximal exertion in
low dynamic moderate dynamic high dynamic
low static class IA n¼3BP
data not valid
class IBn¼38BP
150/90
class ICn¼166BP
200/85
moderate static class IIAn¼23BP
250/100
class IIB n¼12BP
data not valid
class IICn¼49BP
195/70
high static class IIIA n¼19BP
250/95
class IIIB n¼22BP
145/60
class IIIC n¼143BP
200/85
BP ¼ blood pressure in mmHg.
P399
Undetected arterial hypertension - a serious and important risc factor in teenage
athletes: results from a region wide preparticipation study in athletes
A Kassim1, KA Treusch1, A Fruend2, C Beller1, M Vlachojannis1, K Erdsiek1, F Van
Buuren1, KP Mellwig1
1Department of Cardiology, Heart and Diabetes Center, North Rhine-Westphalia, Ruhr Uni-
versity Bochum, Bad Oeynhausen, Germany, 2Department of Physiotherapy, Heart and Diabetes
Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Topic: Sports cardiology
Purpose: Preparticipation screening is recommended by the European Society of Cardiology
(ESC) and were published two years ago. The intention was to reduce sudden cardiac deaths in
athletes and to evaluate athletes for severe heart conditions for their own protection. The
objective of this study was to evaluate the benefitial effects from an additional blood pressure
measurements as it is not specifically mentioned (German society of sports medicine does not
recommend blood pressure measurement for preparticipation screening) and to focus on blood
pressure as an important risc factor in sports activities. As younger athletes come more into focus,
the incidence of high bloodpressure in athletes is unknown.
Methods: According to the ESC and EAPCR guidelines, preparticipation screening (history,
auscultation, ECG and blood pressure measurements) was done in a network setting with 37
physicians with a sports medicine diploma who do regular preparticipation screening. If elevated
blood pressure values (>140/90 mmHg) were present, a second measurement after another 20
minutes of rest was recommended. All athlete files were collected at our center and evaluated.
Starting April 2007 until December 2008, 1024 consecutive athlete-files were evaluated.
Results: We received 1024 screened athlete files. Athletes had to be active at least 4 hours per
week. Age range was 8 to 68 years of age with a mean age of 37.3 years. 727 athletes were male,
297 were female. Mean systolic blood pressure was 135.48 mmHg (range 81 210), mean diastolic
blood pressure was 79,98 mmHg (range 45 118). The results were analysed in decades of age.
145 athletes were 10 to 20 yrs old, 75 athletes were 20 to 30 yrs old. 16.7 % of the female athletes
in the age group 10 20 and 7.9 % in the age group 20 to 30 years had elevated blood pressure
(systolic, diastolic or both). In male athletes 26.6% under the age of 20 (1020) and 59.3 % in the
age group 20 to 30 had elevated blood pressure. 60 of the 220 athletes under the age of 30 yrs had
elevated blood pressure.
Conclusion: Our results show elevated blood pressure values in every fourt young athlete under
the age of 30 with a peak incidence (six out of ten) in male athletes age 20 to 30 yrs. Our small
collectice of 1000 evaluated athletes suggest a higher rate of elevated blood pressure higher
screening numbers. Preparticipation screening with blood pressure screening seems to be
helpful and very important and hypertension screening and control should be evaluated in
further studies.
S88 EuroPRevent Congress Abstracts May 2010
Copyright © European Society of Cardiology. Unauthorized reproduction of this article is prohibited.
POSTER SESSION III
Exercise physiology
Friday, 7 May 2010, 08:30–12:30 Location: Poster Area
P400
Patients with recurrent AF episodes treated with beta-blockers: evaluation of exer-
cise tolerance and quality of life. Prospective, 1-year evaluation
E Smolis-Bak, R Dabrowski, B Kazimierska, I Kowalik, H Szwed
National Institute of Cardiology, Warsaw, Poland
Topic: Exercise physiology, testing and training
Atrial fibrillation [AF] significantly influences everyday performance of patients, their exercise
capacity, quality of life (qol)and psychic condition. The aim of the study was comprehensive
evaluation of 1-year beta-blocker therapy in patients with different forms of AF.
Material and methods: The study group consist of 93 patients, age 40-83 years. There were 42
pts with paroxysmal AF (PAF)-age 668.5, 30 pts with persistent, (PeAF)-age 65.110.1 and 20
pts with chronic (CHAF)-64.0 7.0. All the patients were treated with beta-blockers (propra-
nolol, metoprolol, bisoprolol). During first (V 0) and after 1-year (V 1) visits, pts performed 6
minutes walking test (6-MWT), qol was estimated according to Nottingham Health Profile
questionnaire (NHP) and risk of depression occurrence was estimated by Beck Depression
Inventory scale (BDI).
Results: In 6-MWT resting and maximum heart rate was significantly lower in pts with PAF than
in the pts with CHAF. Walking distance was significantly longer in all studied groups after 1-year
therapy. Pts with CHAF had the longest distance in 6-MWT, but patients with PAF had the
greatest improvement in walking distance. Mild symptoms of depression were diagnosed in pts
with PAF, but not with CHAF and were not changed after 1-year in spite of beta-blocker
therapy. Studied quality of life parameters were not changed in either group after 1-year follow-
up. Generally AF significantly limited (V0 vs V1) professional activity (33% vs 22%), home
activities (30% vs 39%) and sexual activity (30% vs 34%), least of all social life (15% vs 9%) and
family life (15% vs 9%).
Conclusions: 1-year beta-blocker therapy significantly improves exercise tolerance, but not qol
parameters. The depression symptoms were more prevalent in patients with paroxysmal AF, but
in all patients with different forms of AF were not changed during 1-year follow-up in spite of
using older (propranolol) and modern (bisoprolol) beta-blocking drugs.
6 MWT parameters and BDI in AF groups
PAF PeAF CHAF
V o V1 V o V1 V o V1
HR rest 68 8 67 7 70  8 70  9 7210 7813
HR max 84 12 85 10 85  12 88  12 9014 9718
Distance 50598 552105 518123 550127 614115 639132
Beck 11,15,72 10,55,7 9,75,8 10,76,8 8,7 7,5 7,36,7
p<0.05 vs baseline;p<0.05 CHAF vs PAF in the same time
P401
Assessment of functional capacity and stratification patients with isolated left
ventricular diastolic dysfunction
MN Dekleva1, J Suzic Lazic1, S Mazic2
1Clinical Hospital Center Dr D Misovic, University Clinic for Internal Medicine, Belgrade,
Serbia, 2Institute of Physiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Topic: Exercise physiology, testing and training
Cardiopulmonary Exercise Testing (CPET) is a recommended technique for evaluation of
putative mechanism that underlies exercise intolerance in HF. Left ventricle (LV) filling
abnormalities presented by Doppler echocardiography with similar patterns can be actually the
result of different forms of heart disease.
The aim of the study was to assess value of CPET profiles in stratificating patients with different
etiology but similar degree of LVDD.
Methods: LV and left atrium (LA) diameters was measured by M mode echocardiography, LA
and LV volumes normalized by body surface area (EDV/bsa, ESV/bsa), ejection fraction (LVEF)
by biplane Simpson s rule. Mitral inflow velocities (E and A), E/A, dec t E and mitral
regurgitation (MR) were assessed by pulse wave Doppler, velocity propagation (Vp) by Color
M mode and annular e wave by tissue Doppler imaging.
All patients underwent incremental bicycle exercise whereas respiratory exchange ratio >1 was
taken to indicate maximal effort. Peak oxygen uptake (pVO2), oxygen pulse (VO2/HR)
ventilatory anaerobic threshold (VAT) and ventilatory gas equivalents (VE/VO2,VE/VCO2)
were obtained.
Study patients consisted from 50 patients aged 50.76 8.9 with history of hypertension>2 years
and 31 patients aged 49.84  6.9 with history of previous myocardial infarction >1 year. All
patients had mild LVDD i.e. impaired relaxation (E/A<1, DTE>220ms) and preserved systolic
function (EF >50%)
Results: Demographic, Doppler Echocardiographic and Cardiopulmonary characteristics at rest
were similar among two groups. However, significantly higher values of reached pVO2 (1715 vs.
2083 ml, p <0.001), VO2/HR (12 vs. 14.6, p <0.001), and percentage of pVO2 at VAT (55 vs.
64, p ¼ 0.007) were found in patients after AMI compared with hypertensive group. There
were significant correlations in both groups between pVO2 and LV dimensions (LVDD,
LVSD) (r ¼ 0.433, r ¼ 0.513, respectively, p <0.001) , between pVO2 and V max A and E/
em (r ¼ 0.413, r ¼ 0.398, respectively, p <0.001).
Conclusion: CPET is a promising method for identifying patients with impaired physical
performance in early stage of LVDD. CPET profiles can be various, respective to etiology of the
heart disease. Functional capacity in patients with hypertension and coronary disease are closely
related to proper LV expansion during cardiac cycle and degree of impaired LV relaxation.
P402
Development of a regression equation to determine the best six minutewalk distance
(6MWD) in a cardiac rehabilitation (CR) population
J M JenniePatrick1, H Mcburney2
1Caulfield Hospital, Melbourne, Australia, 2LaTrobe University, Bendigo, Australia
Topic: Exercise physiology, testing and training
Purpose: Previous studies of the six minute walk test (6MWT) have indicated that at least two
walks are needed to ensure reproducibility of the 6MWD in the CR population. This study
assessed whether the second 6MWD can be predicted from one 6MWT result.
Method: The 6MWD s from three groups of CR subjects were used. Each 6MWT was
performed over a 25 metre indoor track, with a minimum of 20 minutes rest between walks.
Groups 1 and 2 had performed their tests on admission to CR and Group 3 on discharge.
Group 1 (initial sample, n¼119, 99 male, 20 female, mean age 62.32 12.58 years)
Group 2 (validation sample, n¼156, 119 male, 37 female, mean age 63.0  13.6 years)
Group 3 (discharge sample, n¼85, 57 male, 18 female, mean age 59.92  12.67 years)
Results: For each group there was a high correlation between first and second 6MWD (Group 1
R¼.977, Group 2 R¼.948, Group 3 R¼.963) but also a statistically significant difference between
the mean 6MWD of each walk (p<0.001 for all groups).
Using the data from Group 1, multiple regression was used to generate an equation that could
predict second 6MWD from the variables of: first 6MWD, age, gender, height, weight, body
mass index. A statistically significant equation was generated that used only first 6MWD, age and
a constant. 6MWD2 ¼ (0.986 x 6MWD1) (0.438 x age in years) þ 49.34. Each predictor was
significant within the equation. Using the equation, a predicted 6MWD2 was generated for each
of the three groups and compared to the actual 6MWD2 achieved by each subject.
Correlations between the actual and predicted 6MWD2 for each group were:
Group 1 R ¼.978
Group 2 R ¼.948
Group 3 R¼.963
The mean differences between the actual and predicted 6MWD2 for each group were compared
using paired t tests (see Table 1).
Conclusions: This suggests that for all three groups the mean distances predicted by the
equation for the second walk were close to the actual mean distances walked by the subjects.
Therefore the equation 6MWD2¼ (0.986 x 6MWD1) (0.438 x age in years)þ 49.34 can be used
to reliably predict the second 6MWD from one 6MWT, in the CR population.
Table 1
Group Mean difference (metres) 95% confidence interval for difference t p
1 0.75 4.29 to 4.44 0.034 0.973
2 0.245 5.94 to 5.44 0.87 0.93
3 2.321 8.97 to 4.35 0.69 0.49
Mean differences between actual and predicted 6MWD2 for each group.
P403
Troponin T elevation after endurance exercise is related to running experience
independent of run time and total number of heart beats
P Aagaard, M Stahlberg, A Sahlen, F Braunschweig
Karolinska Institutet, Department of Cardiology, Karolinska University Hospital, Stockholm,
Sweden
Topic: Exercise physiology, testing and training
Background/Objective: Elevation of cardiac troponin is seen after strenuous physical exertion.
Previous reports indicate that this occurs predominantly in inexperienced athletes. A potential
cause for this phenomenon is that inexperienced runners have longer race durations which may
involve a larger total number of heart beats during the race. This study investigated the
association between post-exertional troponin levels, race experience and the number of heart
beats during a long-distance race.
Methods: 34 male participants in a 30 km cross-country race were recruited based on prior
endurance running experience and matched by age: 16 novices (no previous events; 467 ys)
and 18 experienced runners (defined as =10 previous events; 156 events; 486 ys). We
recorded their body mass index (BMI) and analysed their pre- and post-race troponin T levels.
During the race all subjects carried a pulse watch which registered the total number of heart
beats.
Results: Novices had a higher BMI than experienced runners (BMI 25.93.2 vs. 23.82.6 kg/
m2; p¼0.04), they were slower (race duration 20738 vs. 17429 min; p<0.01) and released
more troponin (median 0.03 [IQR 0.0150.06] vs. 0.01 [0.010.02]; p<0.01). The total number of
heart beats differed between groups (325465251 vs. 277854367 beats; p<0.01). When
adjusting for these differences in multivariable analysis, a significant association between
inexperience and post-race troponin elevation (p¼0.03) remained.
Conclusion: Post-exertional troponin release is higher in inexperienced than in experienced
long distance runners. Though these groups differed in terms of BMI and total number of heart
beats during the race, previous race experience was the only independent predictor of troponin
release. This may reflect protective adaptations of cardiac physiology in experienced runners.
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Are recovery VO2 indices necessary for additional evaluation of ischemic patients by
cardiopulmonary exercise test?
E Klainman1, A Yarmolovsky2, R Vishnitzer2, I Rosenberg2, G Fink2
1Gefen Cardiac Health Center, Givatayim, Israel, 2Pulmonary Institute, Kaplan MC, Exercise
Physiology U., Rehovot, Israel
Topic: Exercise physiology, testing and training
Objectives: To assess the significance of recovery VO2 kinetics indices in testing of pts with
various degrees of CAD, in relationship to the exercise cardiopulmonary indices.
Methods: 62 male pts were divided into four groups according to their CAD degree: A:17 normal
subjects (control); B:26 pts with one vessel disease (1VD); C:11 pts with 2VD; D:8 pts with 3VD.
All pts underwent a cardiopulmonary exercise test (CPET), during which peak-VO2, peak-O2P
and VAT, among others, were measured. The recovery indices measured were:1) Half time
recovery(1/2tRec) of VO2; 2)1/2tRec of oxygen pulse(O2P); 3) Total time recovery of VO2
(TtRec-VO2), until RER reached value of 1 or less.
Conclusions: Significant differences in the recovery indices of VO2 kinetics were observed
among the pts with various degrees of CAD and seem to be even more significant than the
exercise CPET indices. Such findings validate the recovery indices as an important addition for
further functional assessment of CAD pts.
Table 1
D(N¼8) C(N¼11) B(N¼26) A(N¼17) Group 1)
18.4þ/6.2 22þ/6.2N˜ 22.5þ/6.6N˜ 25þ/6.4 Peak VO2 (ml/kg/min) 2)
12.5þ/3.2 14.4þ/4.4 16þ/5 15.2þ/2.6 Peak O2P (ml/beat) 3)
44%þ/8 55%þ/8 62%þ/11 56%þ/5 VAT (% of VO2-max) 4)
134þ/18 123þ/36I¨ 100þ/35 84þ/20 1/2tRec-VO2 (sec.) 5)
174þ/40 162þ/37 123þ/34 101þ/30 1/2tRec-O2P (sec.) 6)
9.2þ/1.7 9.1þ/1.9 7.9þ/1.4 7.6þ/1.3 TtRec-VO2 (min.) 7)
P values : Significant:  vs I¨ or ; vs . Borderline:  vs or N˜; vs I¨; I¨ vs ; and vs N˜. Not Significant: 
vs ; vs ; and N˜ vs N˜.
P405
Increased exercise performance in patients with Ebstein’s anomaly after surgical
intervention
J Mueller, A Hager, J Hess
German Heart Center, Clinic at the Technical University of Munich, Munich, Germany
Topic: Exercise physiology, testing and training
Objective:The purpose of the study was to assess whether patients with Ebstein s anomaly profit
from surgical intervention with regard to exercise performance and quality of life.
Patients and methods: In total forty-two patients with Ebstein s anomaly underwent a
cardiopulmonary exercise test in our institution. At the redo test, twenty-one of them had
undergone surgical intervention of their tricuspid valve and, if present, closure of an atrial shunt.
The other twenty-one were free from surgical intervention in between the two tests.
Results: Peak oxygen consumption increased significantly in the intervention group (9.1% vs.
1.7%, p¼0.043) and slope was improved markedly (2.9 vs. 0.8; p<0.001) in contrast to those in
control group. Moreover, oxygen saturation increased significantly at rest (p¼0.001) and under
peak exercise (p¼0.012). The improvements in cardiopulmonary exercise test parameters were
correlated to peak oxygen consumption, ventilation efficiency and oxygen saturation but not
correlated to the operation method, body mass and body height in the intervention group.
Self-estimated quality of life was fairly good, but there were no significant changes when
comparing the differences from pre- and post-testing of the two diagnostic subgroups.
Conclusions: Patients with Ebstein s anomaly profit from surgical intervention and patients with
a bad exercise performance had the greatest improvement in the redo test after surgical
intervention.
P406
The first experince of passive physical trainings in elderly patients with myocardial
infarction
ANAlexeySumin1,AVBezdenezhnykh1,OMBaidina2, TAPopova2,OPHayredinova2
1RAMS Scientific-Research Institute for Complex Studying of Cardiovascular Diseases, Kemer-
ovo, Russian Federation, 2Scientific-Clinical Center of the Miners Health Protection, Leninsk-
Kuznetsky, Russian Federation
Topic: Exercise physiology, testing and training
Purpose: Aging is associated with progressive loss of neuromuscular function. Therefore aged
patients with myocardial infarction (MI) especially require rehabilitation programs. Electrical
stimulation of skeletal muscles (EMS) could represent a rehabilitation alternative for patients
with chronic heart failure. The aim of study was to evaluate the EMS safety and effeciency in
elderly MI patients.
Methods: We examined 57 patients older than 70 yrs (75.40.6 years) with MI. In control group
(n¼25) the patients received only the usual program of phase I rehabilitations, in the EMS group
(n¼32) there was an additional EMS course - 2 times a day for 60 minutes within 10 days. After
course of treatment patients were underwent bicycle ergometric test (VEM), six-minute walking
test (6MWT) and Holter ECG monitoring with estimation of heart rate variability. The
estimation of the left ventricular function was performed by echocadiography.
Results: (see table) The EMS have resulted to more significant increase of maximal VEM
workload, without anything unfluence on left ventricular volumes, number of extrasystoles and
parameters of heart rate variability in Holter monitoring.
Conclusion: Passive physical trainings with EMS result to significant increase of tolerance to
physical loading without negative influence on systolic left ventricular function, autonomic and
arrhythmic status. This method deserves the further application for rehabilitation of elderly MI
patients.
Results of EMS in elderly MI patients
Variables EMS Control P value
6MWT (m) 213.4100.8 136.480.3 0.01
VEM (W) 34.524.3 20.618.2 0.058
RPPmax (u) 136.956.0 115.753.7 0.276
EFLF (%) 43.48.5 46.09.5 0.363
EDVLF (ml) 127.525.6 133.153.0 0.673
SDNN (msec) 104.242.0 109.935.2 0.636
VES 202.6438.6 161.6500.3 0.774
SVES 235.3402.6 443.21290.0 0.451
RPPmax rate-pressure product during maximal workload in VEM, EFLF left ventricular ejection
fraction, EDVLF left ventricular end diastolic volume, VES - ventricular extrasystoles; SVES -
supraventricular extrasystoles, SDNN time domain analyses of heart rate variability.
P407
Causes of positive exercise stress test in post PCI patients undergoing cardiac
rehabilitation; are we missing something?
A Khan, A Mcgowan, R Boner, S Arnous, B Macneil, J Crowley, P Nash, K Daly
University Hospital Galway, Galway, Ireland
Topic: Exercise physiology, testing and training
Purpose: Controversy exists regarding the diagnostic accuracy, optimal technique, and timing of
exercise testing after percutaneous coronary intervention (PCI). The objectives of the present
study were to analyze variables resulting in a positive exercise stress test (EST), in post PCI
patients, undergoing cardiac rehabilitation.
Methods: We performed a retrospective analysis of 116 patients who underwent percutaneous
coronary revascularization and performed exercise stress test after 6 weeks,before undergoing
cardiac rehab.58 patients had a positive exercise stress test while 58 had negative EST.
Demographics, diagnosis on admission, co-morbidities such as DM, HTN, CCF, smoking
status, cholesterol level, diseased arteries, treated and untreated disease, angioplasty ,number
and types of stents used, symptoms and ECG changes during stress test, CABG and repeat
angiogram results were compared between the groups. Diseased artery was defined as =25%
stenosis in a coronary segment.Exercise stress tests were classified as positive or negative
according to ACC guidelines.
Results: In the positive EST group, only 7(12%) had single vessel disease while 51(88%) had
mutivessel disease and stenting - p<0.01.In the negative stress test population 52(90%) had
multivessel disease while 6(10%) had single vessel disease. There was no
significant statistical difference(p>0.5) between status of DM, HTN,CCF, MI, smoking,cho-
lesterol level, untreated diseased arteries, usage of bare metal or drug eluted stents.
Conclusions: The results of this study show that patients with single vessel disease,who remain
symptom free after revascularization, are unlikely to get a positive stress test.In the absence of
symptoms, positive EST is likely to represent minor residual coronary artery disease in
revascularized patients. The presence of cardiac risk factors doesn t seem to play a significant
role in determining the test result.
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Coronary heart disease with depression and studies of serum interleukin-6 level
G Maimaitiming
First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China
Topic: Behavioural medicine
Objectives: This study was conducted to explore the relationship between interleukin6(IL-6)
and coronary heart disease with depression, and sought prognostic role of IL-6,in order to come
up with intervention strategy on treating coronary heart disease patients who were developed
depression. Methods :90 patients with coronary heart disease were recruited into our study,-
according to ZUNG self depression scale (SDS) score,subjects were divided into two groups as,
coronary heart disease with depression (group A) and coronary heart disease without depression
(group B ).
Results: 57.78% of subjects had varying degree of depression, patients with mild depression
were 24 (26.67 %), patients with moderate and severe depression were 28(31.11%); 57.59% of
male patients had depression, and 57.89% of female patients had depression, there was no
statistical difference between two genders when compare the concomitance rate of depression
(P< 0.05); The levels of serum IL-6 in the A group [M(P25, P75)] were [0.04(0.01, 0.06)] ng/ml,
B group were[0.02(0.01,0.05)]ng/ml, group A were significantly higher than the B group
(P<0.05);In the group A, the levels of serum IL-6 patients with moderate and severe depression
were [0.05(0.02,0.08)]ng/ml higher than in patients with mild depression [0.04(0.01,0.05)]ng/ml,
(P<0.05);In the group A the serum IL-6 levels was positively correlated with cholesterol?low-
density lipoprotein?C-reactive protein and left ventricular internal diameter at the end diastolic
left ventricular internal diameter (P<0.05), negatively correlated with left ventricular ejection
fraction (P<0.05), there was no obvious correlation with triglyceride and high-density lipopro-
teins. In the group B the serum IL-6 levels was not obviously correlated to cholesterol?trigly-
ceride?low-density lipoprotein?high-density lipoproteins, C-reactive protein, left ventricular
internal diameter at the end-diastolic and left ventricular ejection. fraction.
Conclusion: The concomitance rate of depression in the coronary heart disease patients were
higher, the level of serum inflammatory markers in coronary heart disease patients with
depression were higher than coronary heart disease patients without depression; In moderate
to severe depressed patients with higher levels of inflammatory markers than in mild depression
patients. Depression is a sign of activation of inflammatory responses; inflammatory responses
play invariably role in coronary heart disease with depression.
Key words: Coronary heart disease; Depression ; IL-6.
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Prevention of oxidative-nitrosative stress activity by atorvastatin at high dose in
patients undergoing aorta-femoral bypass operation
Y V Shchukin, AN Vachev, EI Selesnev, EA Medvedeva, EA Surkova, II Berezin
Samara State Medical University, Samara, Russian Federation
Topic: Lipids and atherosclerosis
Objective: To study atorvastatin influence on the molecular mechanisms of decrease in
oxidative-nitrosative stress, which is the pathogenetic factor for cardiac complications after
the aorta-femoral bypass (AFB) operation.
Methods: 126 patients with atherosclerosis undergoing AFB operation, were included in the
study. The intensity of oxidative-nitrosative stress was determined by the levels of oxidized low-
density lipoproteins (ox-LDL), 3-nitrotyrosine (3-NT) and secretory phospholipase A2 type IIA
(sPLA-A2 IIA) activity. Antioxidant protection system was estimated by glutathione peroxidase
(GPx), extracellular superoxide dismutase (EC-SOD) activity and the level of protein thiol (-
SH) groups. The postoperative myocardial ischemia was determined by means of electrocar-
diography monitoring (Holter). Patients were divided into two groups: 1group - 62 patients
received atorvastatin 60 mg per day during 10-15 days before operation, 2 - 64 patients were
prepared in traditional way. The control group included 36 healthy people.
Results: Before treatment we found increase of oxidative-nitrosative stress in both patients
groups. After atorvastatin treatment we observed increase in activity of GPx (24%, p<0,05), EC-
SOD (22%, p<0,05), level of protein thiol (-SH) groups and decrease in level of 3-NT (27%,
p<0,05), ox-LDL - (24%, p<0,05), sPLA- A2 IIA - (23%, p<0,05). In the second group changes
were not observed. On the first day after operation indicators of oxidative stress were increased
in both patients group, but in the first group less than in the second group difference between
groups was 35-40%. We also found increase in the rate of postoperative myocardial infarction and
ischemia in the second group in comparison with the first one.
Conclusion: Preoperative atorvastatin significantly reduces adverse cardiac events after AFB
operation in patients with atherosclerosis. It may be connected with reduction of vascular and
myocardial oxidative-nitrosative stress.
P410
Combined effect of genetic factors, vitamin status and renal function on plasma
homocysteine level in Russian patients with stable CAD
OO OlgaShakhmatova1, AL Komarov1, DV Rebrikov2, I Koﬁady2, TI Kotkina1, AV
Bolvacheva1, EP Panchenko1
1Russian Cardiology Research & Production Center, Moscow, Russian Federation, 2DNA-
technology, Moscow, Russian Federation
Topic: Genetic-environmental interactions
Moderate hyperhomocysteinemia is an important risk factor for CAD. Common polymorphisms
(MTHFR C677T, MTHFR A1298C, MTR A2756G, MTRR A66G, TCN C776G) and some
clinical factors (reduced folat and cobalamin level, diabetes mellitus (DM), renal insufficiency
and atherosclerotic burden) may contribute to increased homocysteine (Hcy) level.
Purpose: To investigate clinical and genetic determinants of hyperhomocysteinemia in Russian
pts with stable CAD.
Methods: 506 pts (388 male, age 59.412.2 years) with stable CAD were enrolled. Atherosclero-
sis in other vascular beds (cerebrovascular and peripheral vascular diseases) was assessed. Renal
function was estimated by creatinine clearance (CrCl), Cocroft-Gault formula. Hcy, folat and
vitamin B12 plasma concentrations were measured. Polymorphisms were detected based on the
real-time PCR.
Results: Mean Hcy was 14.34.6c¸mol/l. 432 (85.4%) pts had hyperhomocysteinemia (Hcy>10c¸-
mol/l). The frequency of polymorphisms was as follows (hetero-/homozygote): MTHFR 677T
43.3/8.5%, MTHFR 1298C 43.3/12.4%, MTR 2756G 37.0/17.2%, MTRR 66G 38.7/23.6%, TCN
776G 44.7/22.3%. Prevalence of other factors of interest was: low folat plasma level (<7.2 ng/ml)
- 55.5%, low B12 plasma level (<200 pg/ml) - 9.7%, DM - 19%, CrCl<90 ml/min - 53.4%,
coexisting CVD and/or PAOD - 28.8%.
According to univariate analysis, Hcy was related to folat plasma level (Spearman rank 0.23,
p<0.0001), B12 plasma level (Spearman rank0.24, p<0.001) and renal dysfunction (Hcy level:
15.2c¸mol/l for CrCl <90 ml/min vs 13.5c¸mol/l for CrCl > 90 ml/min, p<0.02). According to
ANOVA with continuous covariances (using the nested models), folat plasma level (beta-
coefficient3.86, p<0.0001), cobalamin plasma level (beta5.73, p<0.0001) and MTRR 66AA
genotype (beta 10.71, p<0.0005) were the only three independent predictors of hyperhomo-
cysteinemia. Also Hcy level was related to some combined conditions: MTRR 66G mutation þ
folat plasma level (beta 1.12, p<0.0001), MTRR 66AA genotypeþ cobalamin plasma level (beta
0.012, p<0.0001), TCN 776G mutationþ cobalamin plasma level (beta0.03, p<0.0001), TCN
776G mutation þ folat plasma level (beta 0.58, p<0.0009), MTR 2756G mutation þ cobalamin
plasma level (beta 0.004, p<0.002), MTRR 66G mutation þ CrCl <90 ml/min (beta 0,08,
p<0.001) and TCN 776G mutation þ CrCl <90 ml/min (beta 0,07, p<0.0007).
Conclusion: in Russian pts with stable CAD Hcy level is related to vitamin plasma concen-
trations, MTRR66AA genotype and MTR 2756G, MTRR 66G, TCN 776G mutations with
account taken of vitamin status and renal insufficiency.
P413
Acute exercise increases paracrine activity of circulating angiogenic cells in sedentary
patients with chronic heart failure
E Van Craenenbroeck, V Hoymans, P Beckers, N Possemiers, C Vrints, V Conraads
Antwerp University Hospital, Edegem, Belgium
Topic: Exercise physiology, testing and training
Purpose: The production of angiogenic cytokines is one of the putative mechanisms by which
circulating angiogenic cells (CAC) participate in maintaining normal structure and function of
the endothelial cell-layer. Migratory capacity of CAC is impaired in patients with CHF. This
functional deficit might partially explain endothelial dysfunction, which characterizes CHF
patients and determines exercise capacity. The paracrine function of CAC has not been
investigated in CHF. Therefore, we studied the production of vascular endothelial growth
factor (VEGF) by CAC obtained in CHF patients and healthy subjects. Furthermore, the effect
of a single exercise bout, known to improve CAC migratory capacity, was studied.
Methods: Venous blood was sampled from 21 sedentary CHF patients and 5 healthy subjects
before and after a graded exercise test (GXT). Peripheral blood mononuclear cells were cultured
for 7 days in an endothelial cell medium (EGM-2MV) to generate acLDLþUEA-IþCAC. After
7 days, migratory capacity towards VEGF and SDF-1a was assessed in vitro. For paracrine
activity, cultured CAC were switched to basal medium (no supplemental growth factors) for 72
hours. Conditioned media were collected and assayed for VEGF using ELISA. Supernatant
from human dendritic cells served as negative controls.
Results: Compared to dendritic cells supernatant (no VEGF detected), VEGF levels in
supernatant of CAC cultures from healthy subjects ranged from 75.0 to 143.6 pg/ml. VEGF
concentration was significantly lower in supernatant obtained from CAC from CHF patients
(61.7  11.0 pg/ml, mean  SD) compared to controls (101.3  12.0 pg/ml, p¼ 0.05). Acute
exercise significantly affected VEGF production by CAC. In healthy subjects, VEGF levels
decreased with 41.5 7.4 % post-GXT, whereas in the CHF group an increase of 24.8 16.1 %
was observed (p¼0.002). Migratory capacity towards VEGF and SDF-1a showed a similar
pattern. There was a significant correlation between the change in VEGF levels and the change
in migratory capacity following GXT (p¼0.004, r¼0.541).
Conclusion: Paracrine activity of CAC is impaired in CHF patients and this deficit could
contribute to impaired endothelial repair and hence, endothelial dysfunction. Acute exercise is a
powerful stimulus to improve CAC paracrine function in these patients.
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Comparison of predicted dose vs. actual dose using pharmacogenomic algorithms in
483 patients on long term warfarin therapy
B Diug1, L Shefﬁeld2, M Dooley3, J Lowthian1, S Evans1, E Maxwell4, A Street3, J
Mcneil1
1Monash University, Melbourne, Australia, 2Murdoch Childrens Research Institute, University of
Melbourne, Melbourne, Australia, 3The Alfred Hospital, Melbourne, Australia, 4Melbourne
Pathology, Melbourne, Australia
Topic: Genetic-environmental interactions
Purpose: This study aims to compare the predicted dose against the actual dose using
pharmacogenomics in patients on long-term warfarin therapy in the community. Previous
studies have focussed on pharmacogenomics during initial titration phase however, there is
limited information on its impact on maintenance dosing in patients on long- term warfarin
therapy.
Method:A case control study was conducted with patients recruited by a metropolitan pathology
provider. Warfarin predicted dose was calculated by application of two pharmacogenomic
algorithms. Actual dose was attained from the patient and confirmed by the pathology provider
whereby mean absolute percentage error was calculated (MAPE). Cases had an elevated INR =
6.0 whilst controls were within their therapeutic range for at least 3 months. Patient interviews
investigated demographic and clinical risk factors, time in range and dosage. Height, weight,
waist circumference were measured with DNA obtained through a cheek brush sample for
analysis of genes CYP2C9 and VKORC1.
Results:A total of 483 patients were recruited: 156 cases (mean age 75.4 yrs, range 25-96) and 327
controls (mean age 75.5 yrs, range 36-92).Primary indication for long-term warfarin therapy was
atrial fibrillation (55%) and the predominant race was white (85%) in this cohort. Patients had a
mean height of 167cm (139-198), mean weight of 79.5kg (36-175). Duration of therapy showed
no difference between the two groups with cases on warfarin for a median of 4 years (0.3-31) and
controls 5 years (0.3-31). Mean dosage for cases was 4.5 mg (1-12) whilst controls were 4.3 mg
(0.75-14.5).
Conclusions: Our findings show no difference between the results from the NEJM and Gage
algorithms. However, MAPE showed significant variations between expected and predicted
dosages between our cases and controls in community-based patients on long -term warfarin
maintenance therapy. Further, assessment of these findings is required.
Cases n¼156MAPE(95%CI) Controls n¼327MAPE (95%CI) TotalMAPE(95%CI)
GAGE (2008) 33.2(36.1-40.1) 20.4(21.9-26.5) 27.1(24.4-29.8)
NEJM (2009) 32.3(27.1-37.6) 20.9(24.4-29.0) 28.5(26.2-30.8)
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